Document:

Exhibit 10.1

 

INDEMNITY AGREEMENT

 

THIS INDEMNITY AGREEMENT (this “Agreement”)
is made as of February 5, 2020, by and between RMG Acquisition Corp., a Delaware corporation (the “Company”),
and Steven Buffone (“Indemnitee”).

 

RECITALS

 

WHEREAS, highly competent persons have become
more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless they are provided with
adequate protection through insurance or adequate indemnification against inordinate risks of claims and actions against them arising
out of their service to and activities on behalf of such corporations;

 

WHEREAS, the Board of Directors of the Company
(the “Board”) has determined that, in order to attract and retain qualified individuals, the Company will attempt
to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company and its subsidiaries
from certain liabilities. Although the furnishing of such insurance has been a customary and widespread practice among United States-based
corporations and other business enterprises, the Company believes that, given current market conditions and trends, such insurance
may be available to it in the future only at higher premiums and with more exclusions. At the same time, directors, officers and
other persons in service to corporations or business enterprises are being increasingly subjected to expensive and time-consuming
litigation relating to, among other things, matters that traditionally would have been brought only against the Company or business
enterprise itself. The Amended and Restated Certificate of Incorporation (the “Charter”) and the Bylaws (the
 “Bylaws”) of the Company require indemnification of the officers and directors of the Company. Indemnitee may
also be entitled to indemnification pursuant to applicable provisions of the Delaware General Corporation Law (“DGCL”).
The Charter, Bylaws and the DGCL expressly provide that the indemnification provisions set forth therein are not exclusive, and
thereby contemplate that contracts may be entered into between the Company and members of the Board, officers and other persons
with respect to indemnification, hold harmless, exoneration, advancement and reimbursement rights;

 

WHEREAS, the uncertainties relating to such
insurance and to indemnification have increased the difficulty of attracting and retaining such persons;

 

WHEREAS, the Board has determined that the
increased difficulty in attracting and retaining such persons is detrimental to the best interests of the Company’s stockholders
and that the Company should act to assure such persons that there will be increased certainty of such protection in the future;

 

WHEREAS, it is reasonable, prudent and necessary
for the Company contractually to obligate itself to indemnify, hold harmless, exonerate and to advance expenses on behalf of, such
persons to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company free from undue
concern that they will not be so protected against liabilities;

 

WHEREAS, this Agreement is a supplement
to and in furtherance of the Charter and Bylaws of the Company and any resolutions adopted pursuant thereto, and shall not be deemed
a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder;

 

WHEREAS, Indemnitee may not be willing to
serve as an officer or director, advisor or in another capacity without adequate protection, and the Company desires Indemnitee
to serve in such capacity. Indemnitee is willing to serve, continue to serve and to take on additional service for or on behalf
of the Company on the condition that Indemnitee be so indemnified; and

 

NOW, THEREFORE, in consideration of the
premises and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree as follows:

 

     

     

    

 

TERMS AND CONDITIONS

 

Article
I.

Services to the Company

 

In consideration of the Company’s
covenants and obligations hereunder, Indemnitee will serve or continue to serve as an officer, director, advisor, key employee
or any other capacity of the Company, as applicable, for so long as Indemnitee is duly elected or appointed or retained or until
Indemnitee tenders Indemnitee’s resignation or until Indemnitee is removed. The foregoing notwithstanding, this Agreement
shall continue in full force and effect after Indemnitee has ceased to serve as a director, officer, advisor, key employee or in
any other capacity of the Company, as provided in Article XVII. This Agreement, however, shall not impose any obligation
on Indemnitee or the Company to continue Indemnitee’s service to the Company beyond any period otherwise required by law
or by other agreements or commitments of the parties, if any.

 

Article
II.

Definitions

 

As used in this Agreement:

 

(a) References to “agent”
shall mean any person who is or was a director, officer or employee of the Company or a subsidiary of the Company or other person
authorized by the Company to act for the Company, to include such person serving in such capacity as a director, officer, employee,
fiduciary or other official of another corporation, partnership, limited liability company, joint venture, trust or other enterprise
at the request of, for the convenience of, or to represent the interests of the Company or a subsidiary of the Company.

 

(b) The terms “Beneficial Owner”
and “Beneficial Ownership” shall have the meanings set forth in Rule 13d-3 promulgated under the Exchange Act
(as defined below) as in effect on the date hereof.

 

(c) A “Change in Control”
shall be deemed to occur upon the earliest to occur after the date of this Agreement of any of the following events:

 

(i) Acquisition of Stock by
Third Party. Other than an affiliate of RMG Sponsor, LLC, a Delaware limited liability company (“RMG Sponsor”),
any Person (as defined below) is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing
fifteen percent (15%) or more of the combined voting power of the Company’s then outstanding securities entitled to vote
generally in the election of directors, unless (1) the change in the relative Beneficial Ownership of the Company’s securities
by any Person results solely from a reduction in the aggregate number of outstanding shares of securities entitled to vote generally
in the election of directors, or (2) such acquisition was approved in advance by the Continuing Directors (as defined below) and
such acquisition would not constitute a Change in Control under part (iii) of this definition;

 

(ii) Change in Board of Directors. Individuals who, as of the date hereof, constitute the Board, and any new director
whose election by the Board or nomination for election by the Company’s stockholders was approved by a vote of at least two
thirds of the directors then still in office who were directors on the date hereof or whose election for nomination for election
was previously so approved (collectively, the “Continuing Directors”), cease for any reason to constitute at
least a majority of the members of the Board;

 

(iii) Corporate Transactions. The effective date of a merger, capital stock exchange, asset acquisition, stock purchase,
reorganization or similar business combination, involving the Company and one or more businesses (a “Business Combination”),
in each case, unless, following such Business Combination: (1) all or substantially all of the individuals and entities who were
the Beneficial Owners of securities entitled to vote generally in the election of directors immediately prior to such Business
Combination beneficially own, directly or indirectly, more than fifty-one percent (51%) of the combined voting power of the then
outstanding securities of the Company entitled to vote generally in the election of directors resulting from such Business Combination
(including, without limitation, a corporation which as a result of such transaction owns the Company or all or substantially all
of the Company’s assets either directly or through one or more Subsidiaries (as defined below)) in substantially the same
proportions as their ownership immediately prior to such Business Combination, of the securities entitled to vote generally in
the election of directors; (2) other than an affiliate of RMG Sponsor, no Person (excluding any corporation resulting from such
Business Combination) is the Beneficial Owner, directly or indirectly, of fifteen percent (15%) or more of the combined voting
power of the then outstanding securities entitled to vote generally in the election of directors of the surviving corporation except
to the extent that such ownership existed prior to the Business Combination; and (3) at least a majority of the Board of Directors
of the corporation resulting from such Business Combination were Continuing Directors at the time of the execution of the initial
agreement, or of the action of the Board of Directors, providing for such Business Combination;

 

     

     

    

 

(iv) Liquidation. The approval by the stockholders of the Company of a complete liquidation of the Company or an agreement
or series of agreements for the sale or disposition by the Company of all or substantially all of the Company’s assets, other
than factoring the Company’s current receivables or escrows due (or, if such stockholder approval is not required, the decision
by the Board to proceed with such a liquidation, sale, or disposition in one transaction or a series of related transactions);
or

 

(v) Other Events. There occurs any other event of a nature that would be required to be reported in response to Item
6(e) of Schedule 14A of Regulation 14A (or any successor rule) (or a response to any similar item on any similar schedule or form)
promulgated under the Exchange Act (as defined below), whether or not the Company is then subject to such reporting requirement.

 

(d) “Corporate Status” describes the status of a person who is or was a director, officer, trustee, general
partner, manager, managing member, fiduciary, employee or agent of the Company or of any other Enterprise (as defined below) which
such person is or was serving at the request of the Company.

 

(e) “Delaware Court” shall mean the Court of Chancery of the State of Delaware.

 

(f) “Disinterested Director” shall mean a director of the Company who is not and was not a party to the
Proceeding (as defined below) in respect of which indemnification is sought by Indemnitee.

 

(g) “Enterprise” shall mean the Company and any other corporation, constituent corporation (including any
constituent of a constituent) absorbed in a consolidation or merger to which the Company (or any of its wholly owned subsidiaries)
is a party, limited liability company, partnership, joint venture, trust, employee benefit plan or other enterprise of which Indemnitee
is or was serving at the request of the Company as a director, officer, trustee, general partner, manager, managing member, fiduciary,
employee or agent.

 

(h) “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended.

 

(i) “Expenses” shall include all direct and indirect costs, fees and expenses of any type or nature whatsoever,
including, without limitation, all reasonable attorneys’ fees and costs, retainers, court costs, transcript costs, fees of
experts, witness fees, travel expenses, fees of private investigators and professional advisors, duplicating costs, printing and
binding costs, telephone charges, postage, delivery service fees, fax transmission charges, secretarial services and all other
disbursements, obligations or expenses in connection with prosecuting, defending, preparing to prosecute or defend, investigating,
being or preparing to be a witness in, settlement or appeal of, or otherwise participating in, a Proceeding (as defined below),
including reasonable compensation for time spent by Indemnitee for which he or she is not otherwise compensated by the Company
or any third party. Expenses also shall include Expenses incurred in connection with any appeal resulting from any Proceeding (as
defined below), including without limitation the principal, premium, security for, and other costs relating to any cost bond, supersede
as bond, or other appeal bond or its equivalent. “Expenses,” however, shall not include amounts paid in settlement
by Indemnitee or the amount of judgments or fines against Indemnitee.

 

(j) References to “fines” shall include any excise
tax assessed on Indemnitee with respect to any employee benefit plan; references to “serving at the request of the Company”
shall include any service as a director, officer, employee, agent or fiduciary of the Company which imposes duties on, or involves
services by, such director, officer, employee, agent or fiduciary with respect to an employee benefit plan, its participants or
beneficiaries; and if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in the best interests
of the participants and beneficiaries of an employee benefit plan, Indemnitee shall be deemed to have acted in a manner “not
opposed to the best interests of the Company” as referred to in this Agreement.

 

     

     

    

 

(k) “Independent Counsel”
shall mean a law firm or a member of a law firm with significant experience in matters of corporation law and that neither presently
is, nor in the past five years has been, retained to represent: (i) the Company or Indemnitee in any matter material to either
such party (other than with respect to matters concerning Indemnitee under this Agreement, or of other indemnitees under similar
indemnification agreements); or (ii) any other party to the Proceeding (as defined below) giving rise to a claim for indemnification
hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not include any person who, under the
applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company
or Indemnitee in an action to determine Indemnitee’s rights under this Agreement.

 

(l) The term “Person” shall have the meaning as set forth in Sections 13(d) and 14(d) of the Exchange Act
as in effect on the date hereof; provided, however, that “Person” shall exclude: (i) the Company; (ii) any Subsidiaries
(as defined below) of the Company; (iii) any employment benefit plan of the Company or of a Subsidiary (as defined below) of the
Company or of any corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions
as their ownership of stock of the Company; and (iv) any trustee or other fiduciary holding securities under an employee benefit
plan of the Company or of a Subsidiary (as defined below) of the Company or of a corporation owned directly or indirectly by the
stockholders of the Company in substantially the same proportions as their ownership of stock of the Company.

 

(m) The term “Proceeding” shall include any threatened, pending or completed action, suit, arbitration,
mediation, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened
or completed proceeding, whether brought in the right of the Company or otherwise and whether of a civil (including intentional
or unintentional tort claims), criminal, administrative or investigative or related nature, in which Indemnitee was, is, will or
might be involved as a party or otherwise by reason of the fact that Indemnitee is or was a director or officer of the Company,
by reason of any action (or failure to act) taken by Indemnitee or of any action (or failure to act) on Indemnitee’s part
while acting as a director or officer of the Company, or by reason of the fact that Indemnitee is or was serving at the request
of the Company as a director, officer, trustee, general partner, manager, managing member, fiduciary, employee or agent of any
other Enterprise, in each case whether or not serving in such capacity at the time any liability or expense is incurred for which
indemnification, reimbursement, or advancement of expenses can be provided under this Agreement.

  

(n) The term “Subsidiary,”
with respect to any Person, shall mean any corporation, limited liability company, partnership, joint venture, trust or other entity
of which a majority of the voting power of the voting equity securities or equity interest is owned, directly or indirectly, by
that Person.

  

Article
III.

Indemnity in Third-Party Proceedings

 

To the fullest extent permitted by applicable
law, the Company shall indemnify, hold harmless and exonerate Indemnitee in accordance with the provisions of this Article III
if Indemnitee was, is, or is threatened to be made, a party to or a participant (as a witness, deponent or otherwise) in any Proceeding,
other than a Proceeding by or in the right of the Company to procure a judgment in its favor by reason of Indemnitee’s Corporate
Status. Pursuant to this Article III, Indemnitee shall be indemnified, held harmless and exonerated against all Expenses,
judgments, liabilities, fines, penalties and amounts paid in settlement (including all interest, assessments and other charges
paid or payable in connection with or in respect of such Expenses, judgments, fines, penalties and amounts paid in settlement)
actually, and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection with such Proceeding or any claim,
issue or matter therein, if Indemnitee acted in good faith and in a manner he or she reasonably believed to be in or not opposed
to the best interests of the Company and, in the case of a criminal Proceeding, had no reasonable cause to believe that Indemnitee’s
conduct was unlawful.

  

Article
IV.

Indemnity in Proceedings by or in the Right of the Company

 

To the fullest extent permitted by applicable
law, the Company shall indemnify, hold harmless and exonerate Indemnitee in accordance with the provisions of this Article IV
if Indemnitee was, is, or is threatened to be made, a party to or a participant (as a witness, deponent or otherwise) in any Proceeding
by or in the right of the Company to procure a judgment in its favor by reason of Indemnitee’s Corporate Status. Pursuant
to this Article IV, Indemnitee shall be indemnified, held harmless and exonerated against all Expenses actually and reasonably
incurred by Indemnitee or on Indemnitee’s behalf in connection with such Proceeding or any claim, issue or matter therein,
if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests
of the Company. No indemnification, hold harmless or exoneration for Expenses shall be made under this Article IV in respect
of any claim, issue or matter as to which Indemnitee shall have been finally adjudged by a court to be liable to the Company, unless
and only to the extent that any court in which the Proceeding was brought or the Delaware Court shall determine upon application
that, despite the adjudication of liability but in view of all the circumstances of the case, Indemnitee is fairly and reasonably
entitled to indemnification, to be held harmless or to exoneration.

 

     

     

    

 

Article
V.

Indemnification for the Expenses of a Party who is Wholly or Partly Successful

 

Notwithstanding any other provisions of
this Agreement except for Article XXVII, to the extent that Indemnitee was or is, by reason of Indemnitee’s Corporate
Status, a party to (or a participant in) and is successful, on the merits or otherwise, in any Proceeding or in defense of any
claim, issue or matter therein, in whole or in part, the Company shall, to the fullest extent permitted by applicable law, indemnify,
hold harmless and exonerate Indemnitee against all Expenses actually and reasonably incurred by Indemnitee in connection therewith.
If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but
less than all claims, issues or matters in such Proceeding, the Company shall, to the fullest extent permitted by applicable law,
indemnify, hold harmless and exonerate Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s
behalf in connection with each successfully resolved claim, issue or matter. If Indemnitee is not wholly successful in such Proceeding,
the Company also shall, to the fullest extent permitted by applicable law, indemnify, hold harmless and exonerate Indemnitee against
all Expenses reasonably incurred in connection with a claim, issue or matter related to any claim, issue, or matter on which Indemnitee
was successful. For purposes of this Article and without limitation, the termination of any claim, issue or matter in such a Proceeding
by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter.

 

Article VI.

Indemnification for Expenses of a Witness

 

Notwithstanding any other provision of this
Agreement except for Article XXVII, to the extent that Indemnitee is, by reason of Indemnitee’s Corporate Status,
a witness or deponent in any Proceeding to which Indemnitee was or is not a party or threatened to be made a party, Indemnitee
shall, to the fullest extent permitted by applicable law, be indemnified, held harmless and exonerated against all Expenses actually
and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection therewith.

 

Article VII.

Additional Indemnification, Hold Harmless and
Exoneration Rights

 

Notwithstanding any limitation in Articles
III, IV, or V, except for Article XXVII, the Company shall, to the fullest extent permitted by applicable
law, indemnify, hold harmless and exonerate Indemnitee if Indemnitee is a party to or threatened to be made a party to any Proceeding
(including a Proceeding by or in the right of the Company to procure a judgment in its favor) against all Expenses, judgments,
fines, penalties and amounts paid in settlement (including all interest, assessments and other charges paid or payable in connection
with or in respect of such Expenses, judgments, fines, penalties and amounts paid in settlement) actually and reasonably incurred
by Indemnitee in connection with the Proceeding. No indemnification, hold harmless or exoneration rights shall be available under
this Article VII on account of Indemnitee’s conduct which constitutes a breach of Indemnitee’s duty of loyalty
to the Company or its stockholders or is an act or omission not in good faith or which involves intentional misconduct or a knowing
violation of the law.

  

Article
VIII.

Contribution in the Event of Joint Liability

 

(a) To the fullest extent permissible under
applicable law, if the indemnification, hold harmless and/or exoneration rights provided for in this Agreement are unavailable
to Indemnitee in whole or in part for any reason whatsoever, the Company, in lieu of indemnifying, holding harmless or exonerating
Indemnitee, shall pay, in the first instance, the entire amount incurred by Indemnitee, whether for judgments, liabilities, fines,
penalties, amounts paid or to be paid in settlement and/or for Expenses, in connection with any Proceeding without requiring Indemnitee
to contribute to such payment, and the Company hereby waives and relinquishes any right of contribution it may have at any time
against Indemnitee.

 

     

     

    

 

(b) The Company shall not enter into any
settlement of any Proceeding in which the Company is jointly liable with Indemnitee (or would be if joined in such Proceeding)
unless such settlement provides for a full and final release of all claims asserted against Indemnitee.

  

(c) The Company hereby agrees to fully indemnify,
hold harmless and exonerate Indemnitee from any claims for contribution which may be brought by officers, directors or employees
of the Company other than Indemnitee who may be jointly liable with Indemnitee.

 

Article
IX.

Exclusions

 

Notwithstanding any provision in this Agreement,
the Company shall not be obligated under this Agreement to make any indemnification, advance expenses, hold harmless or exoneration
payment in connection with any claim made against Indemnitee:

  

(a) for which payment has actually been
received by or on behalf of Indemnitee under any insurance policy or other indemnity or advancement provision, except with respect
to any excess beyond the amount actually received under any insurance policy, contract, agreement, other indemnity or advancement
provision or otherwise;

 

(b) for an accounting of profits made from
the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within the meaning of Section 16(b) of
the Exchange Act (or any successor rule) or similar provisions of state statutory law or common law; or

 

(c) except as otherwise provided in Article
XIV(f) to Article XIV(g) hereof, prior to a Change in Control, in connection with any Proceeding (or any part of any
Proceeding) initiated by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee against the
Company or its directors, officers, employees or other indemnitees, unless (i) the Board authorized the Proceeding (or any part
of any Proceeding) prior to its initiation or (ii) the Company provides the indemnification, hold harmless or exoneration payment,
in its sole discretion, pursuant to the powers vested in the Company under applicable law. Indemnitee shall seek payments or advances
from the Company only to the extent that such payments or advances are unavailable from any insurance policy of the Company covering
Indemnitee.

 

Article
X.

Advances of Expenses; Defense of Claim

 

(a) Notwithstanding any provision of this
Agreement to the contrary, except for Article XXVII, and to the fullest extent not prohibited by applicable law, the Company
shall pay the Expenses incurred by Indemnitee (or reasonably expected by Indemnitee to be incurred by Indemnitee within three months)
in connection with any Proceeding within ten (10) days after the receipt by the Company of a statement or statements requesting
such advances from time to time, prior to the final disposition of any Proceeding. Advances shall, to the fullest extent permitted
by law, be unsecured and interest free. Advances shall, to the fullest extent permitted by law, be made without regard to Indemnitee’s
ability to repay the Expenses and without regard to Indemnitee’s ultimate entitlement to be indemnified, held harmless or
exonerated under the other provisions of this Agreement. Advances shall include any and all reasonable Expenses incurred pursuing
a Proceeding to enforce this right of advancement, including Expenses incurred preparing and forwarding statements to the Company
to support the advances claimed. To the fullest extent required by applicable law, such payments of Expenses in advance of the
final disposition of the Proceeding shall be made only upon the Company’s receipt of an undertaking, by or on behalf of Indemnitee,
to repay the advanced amounts to the extent that it is ultimately determined that Indemnitee is not entitled to be indemnified,
held harmless or exonerated by the Company under the provisions of this Agreement, the Charter, the Bylaws of the Company, applicable
law or otherwise. This Article X(a) shall not apply to any claim made by Indemnitee for which an indemnification, hold harmless
or exoneration payment is excluded pursuant to Article IX.

 

     

     

    

 

(b) The Company will be entitled to participate
in the Proceeding at its own expense.

 

(c) The Company shall not settle any action,
claim or Proceeding (in whole or in part) which would impose any Expense, judgment, fine, penalty or limitation on Indemnitee without
Indemnitee’s prior written consent.

  

Article
XI.

Procedure for Notification and Application for Indemnification

 

(a) Indemnitee agrees to notify promptly
the Company in writing upon being served with any summons, citation, subpoena, complaint, indictment, information or other document
relating to any Proceeding, claim, issue or matter therein which may be subject to indemnification, hold harmless or exoneration
rights, or advancement of Expenses covered hereunder. The failure of Indemnitee to so notify the Company shall not relieve the
Company of any obligation which it may have to Indemnitee under this Agreement, or otherwise.

  

(b) Indemnitee may deliver to the Company
a written application to indemnify, hold harmless or exonerate Indemnitee in accordance with this Agreement. Such application(s)
may be delivered from time to time and at such time(s) as Indemnitee deems appropriate in his or her sole discretion. Following
such a written application for indemnification by Indemnitee, Indemnitee’s entitlement to indemnification shall be determined
according to Article XII(a) of this Agreement.

  

Article
XII.

Procedure upon Application for Indemnification

 

(a) A determination, if required by applicable
law, with respect to Indemnitee’s entitlement to indemnification shall be made in the specific case by one of the following
methods, which shall be at the election of Indemnitee: (i) by a majority vote of the Disinterested Directors, even though less
than a quorum of the Board, (ii) by a committee of such directors designated by majority vote of such directors, (iii) if there
are no Disinterested Directors or if such directors so direct, by Independent Counsel in a written opinion to the Board, a copy
of which shall be delivered to Indemnitee, or (iv) by vote of the stockholders. The Company promptly will advise Indemnitee in
writing with respect to any determination that Indemnitee is or is not entitled to indemnification, including a description of
any reason or basis for which indemnification has been denied. If it is so determined that Indemnitee is entitled to indemnification,
payment to Indemnitee shall be made within ten (10) days after such determination. Indemnitee shall reasonably cooperate with the
person, persons or entity making such determination with respect to Indemnitee’s entitlement to indemnification, including
providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged
or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination.
Any costs or Expenses (including reasonable attorneys’ fees and disbursements) incurred by Indemnitee in so cooperating with
the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination as to
Indemnitee’s entitlement to indemnification) and the Company hereby agrees to indemnify and to hold Indemnitee harmless therefrom.

 

(b) In the event the determination of entitlement
to indemnification is to be made by Independent Counsel pursuant to Article XII(a) hereof, the Independent Counsel shall
be selected as provided in this Article XII(b). The Independent Counsel shall be selected by Indemnitee (unless Indemnitee
shall request that such selection be made by the Board), and Indemnitee shall give written notice to the Company advising it of
the identity of the Independent Counsel so selected and certifying that the Independent Counsel so selected meets the requirements
of “Independent Counsel” as defined in Article II of this Agreement. If the Independent Counsel is selected
by the Board, the Company shall give written notice to Indemnitee advising Indemnitee of the identity of the Independent Counsel
so selected and certifying that the Independent Counsel so selected meets the requirements of “Independent Counsel”
as defined in Article II of this Agreement. In either event, Indemnitee or the Company, as the case may be, may, within
ten (10) days after such written notice of selection shall have been received, deliver to the Company or to Indemnitee, as the
case may be, a written objection to such selection; provided, however, that such objection may be asserted only on the ground that
the Independent Counsel so selected does not meet the requirements of “Independent Counsel” as defined in Article
II of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion. Absent a proper
and timely objection, the person so selected shall act as Independent Counsel. If such written objection is so made and substantiated,
the Independent Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court
of competent jurisdiction has determined that such objection is without merit. If, within twenty (20) days after submission by
Indemnitee of a written request for indemnification pursuant to Article XI(b) hereof, no Independent Counsel shall have
been selected and not objected to, either the Company or Indemnitee may petition the Delaware Court for resolution of any objection
which shall have been made by the Company or Indemnitee to the other’s selection of Independent Counsel and/or for the appointment
as Independent Counsel of a person selected by the Delaware Court, and the person with respect to whom all objections are so resolved
or the person so appointed shall act as Independent Counsel under Article XII(a) hereof. Upon the due commencement of any
judicial proceeding or arbitration pursuant to Article XII(a) of this Agreement, Independent Counsel shall be discharged
and relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing).

 

     

     

    

 

(c) The Company agrees to pay the reasonable
fees and expenses of Independent Counsel and to fully indemnify and hold harmless such Independent Counsel against any and all
Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement pursuant hereto.

  

Article
XIII.

Presumptions and Effect of Certain Proceedings

 

(a) In making a determination with respect
to entitlement to indemnification hereunder, the person, persons or entity making such determination shall presume that Indemnitee
is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in accordance with
Article XI(b) of this Agreement, and the Company shall have the burden of proof to overcome that presumption in connection
with the making by any person, persons or entity of any determination contrary to that presumption. Neither the failure of the
Company (including by the Disinterested Directors or Independent Counsel) to have made a determination prior to the commencement
of any action pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable
standard of conduct, nor an actual determination by the Company (including by the Disinterested Directors or Independent Counsel)
that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that
Indemnitee has not met the applicable standard of conduct.

  

(b) If the person, persons or entity empowered
or selected under Article XII of this Agreement to determine whether Indemnitee is entitled to indemnification shall not
have made a determination within thirty (30) days after receipt by the Company of the request therefor, the requisite determination
of entitlement to indemnification shall, to the fullest extent permitted by law, be deemed to have been made and Indemnitee shall
be entitled to such indemnification, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact
necessary to make Indemnitee’s statement not materially misleading, in connection with the request for indemnification, or
(ii) a final judicial determination that any or all such indemnification is expressly prohibited under applicable law; provided,
however, that such thirty (30)-day period may be extended for a reasonable time, not to exceed an additional fifteen (15) days,
if the person, persons or entity making the determination with respect to entitlement to indemnification in good faith requires
such additional time for the obtaining or evaluating of documentation and/or information relating thereto.

 

(c) The termination of any Proceeding or
of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of nolo contendere or its equivalent,
shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect the right of Indemnitee to indemnification
or create a presumption that Indemnitee did not act in good faith and in a manner which Indemnitee reasonably believed to be in
or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable
cause to believe that Indemnitee’s conduct was unlawful.

  

     

     

    

 

(d) For purposes of any determination of
good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee’s action is based on the records or books
of account of the Enterprise, including financial statements, or on information supplied to Indemnitee by the directors, managers,
or officers of the Enterprise in the course of their duties, or on the advice of legal counsel for the Enterprise, its Board, any
committee of the Board or any director, trustee, general partner, manager or managing member, or on information or records given
or reports made to the Enterprise, its Board, any committee of the Board or any director, trustee, general partner, manager or
managing member, by an independent certified public accountant or by an appraiser or other expert selected by the Enterprise, its
Board, any committee of the Board or any director, trustee, general partner, manager or managing member. The provisions of this
Article XIII(d) shall not be deemed to be exclusive or to limit in any way the other circumstances in which Indemnitee may
be deemed or found to have met the applicable standard of conduct set forth in this Agreement.

  

(e) The knowledge and/or actions, or failure
to act, of any other director, officer, trustee, partner, manager, managing member, fiduciary, agent or employee of the Enterprise
shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement.

  

Article
XIV.

Remedies of Indemnitee

 

(a) In the event that (i) a determination
is made pursuant to Article XII of this Agreement that Indemnitee is not entitled to indemnification under this Agreement,
(ii) advancement of Expenses, to the fullest extent permitted by applicable law, is not timely made pursuant to Article X
of this Agreement, (iii) no determination of entitlement to indemnification shall have been made pursuant to Article XII(a)
of this Agreement within thirty (30) days after receipt by the Company of the request for indemnification, (iv) payment of indemnification
is not made pursuant to Articles V, VI, VII or the last sentence of Article XII(a) of this Agreement
within ten (10) days after receipt by the Company of a written request therefor, (v) a contribution payment is not made in a timely
manner pursuant to Article VIII of this Agreement, (vi) payment of indemnification pursuant to Article III or IV
of this Agreement is not made within ten (10) days after a determination has been made that Indemnitee is entitled to indemnification,
or (vii) payment to Indemnitee pursuant to any hold harmless or exoneration rights under this Agreement or otherwise is not made
in accordance with this Agreement, Indemnitee shall be entitled to an adjudication by the Delaware Court to such indemnification,
hold harmless, exoneration, contribution or advancement rights. Alternatively, Indemnitee, at Indemnitee’s option, may seek
an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration
Association. Except as set forth herein, the provisions of Delaware law (without regard to its conflict of laws rules) shall apply
to any such arbitration. The Company shall not oppose Indemnitee’s right to seek any such adjudication or award in arbitration.

  

(b) In the event that a determination shall
have been made pursuant to Article XII(a) of this Agreement that Indemnitee is not entitled to indemnification, any judicial
proceeding or arbitration commenced pursuant to this Article XIV shall be conducted in all respects as a de novo trial,
or arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination.

  

(c) In any judicial proceeding or arbitration
commenced pursuant to this Article XIV, Indemnitee shall be presumed to be entitled to be indemnified, held harmless, exonerated
and to receive advancement of Expenses under this Agreement and the Company shall have the burden of proving Indemnitee is not
entitled to be indemnified, held harmless, exonerated and to receive advancement of Expenses, as the case may be, and the Company
may not refer to or introduce into evidence any determination pursuant to Article XII(a) of this Agreement adverse to Indemnitee
for any purpose. If Indemnitee commences a judicial proceeding or arbitration pursuant to this Article XIV, Indemnitee shall
not be required to reimburse the Company for any advances pursuant to Article X until a final determination is made with
respect to Indemnitee’s entitlement to indemnification (as to which all rights of appeal have been exhausted or lapsed).

  

(d) If a determination shall have been made
pursuant to Article XII(a) of this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound
by such determination in any judicial proceeding or arbitration commenced pursuant to this Article XIV, absent (i) a misstatement
by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially
misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable
law.

 

     

     

    

 

(e) The Company shall be precluded from
asserting in any judicial proceeding or arbitration commenced pursuant to this Article XIV that the procedures and presumptions
of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or before any such arbitrator that
the Company is bound by all the provisions of this Agreement.

  

(f) The Company shall indemnify and hold
harmless Indemnitee to the fullest extent permitted by law against all Expenses and, if requested by Indemnitee, shall (within
ten (10) days after the Company’s receipt of such written request) pay to Indemnitee, to the fullest extent permitted by
applicable law, such Expenses which are incurred by Indemnitee in connection with any judicial proceeding or arbitration brought
by Indemnitee: (i) to enforce his or her rights under, or to recover damages for breach of, this Agreement or any other indemnification,
hold harmless, exoneration, advancement or contribution agreement or provision of the Charter or the Bylaws now or hereafter in
effect; or (ii) for recovery or advances under any insurance policy maintained by any person for the benefit of Indemnitee, regardless
of the outcome and whether Indemnitee ultimately is determined to be entitled to such indemnification, hold harmless or exoneration
right, advancement, contribution or insurance recovery, as the case may be (unless such judicial proceeding or arbitration was
not brought by Indemnitee in good faith).

  

(g) Interest shall be paid by the Company
to Indemnitee at the legal rate under Delaware law for amounts which the Company indemnifies, holds harmless or exonerates, or
advances, or is obliged to indemnify, hold harmless or exonerate or advance for the period commencing with the date on which Indemnitee
requests indemnification, to be held harmless, exonerated, contribution, reimbursement or advancement of any Expenses and ending
with the date on which such payment is made to Indemnitee by the Company.

 

Article
XV.

Security

 

Notwithstanding anything herein to the contrary,
except for Article XXVII, to the extent requested by Indemnitee and approved by the Board, the Company may at any time and
from time to time provide security to Indemnitee for the Company’s obligations hereunder through an irrevocable bank line
of credit, funded trust or other collateral. Any such security, once provided to Indemnitee, may not be revoked or released without
the prior written consent of Indemnitee.

  

Article
XVI.

Non-Exclusivity; Survival of Rights; Insurance; Subrogation

 

(a) The rights of Indemnitee as provided
by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled under applicable
law, the Charter, the Bylaws, any agreement, a vote of stockholders or a resolution of directors, or otherwise. No amendment,
alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement
in respect of any Proceeding (regardless of when such Proceeding is first threatened, commenced or completed) or claim, issue
or matter therein arising out of, or related to, any action taken or omitted by such Indemnitee in Indemnitee’s Corporate
Status prior to such amendment, alteration or repeal. To the extent that a change in applicable law, whether by statute or judicial
decision, permits greater indemnification, hold harmless or exoneration rights or advancement of Expenses than would be afforded
currently under the Charter, the Bylaws or this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy
by this Agreement the greater benefits so afforded by such change. No right or remedy herein conferred is intended to be exclusive
of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy
given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy
hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy.

 

(b) The DGCL, the Charter and the Bylaws
permit the Company to purchase and maintain insurance or furnish similar protection or make other arrangements including, but not
limited to, providing a trust fund, letter of credit, or surety bond (“Indemnification Arrangements”) on behalf
of Indemnitee against any liability asserted against Indemnitee or incurred by or on behalf of Indemnitee or in such capacity as
a director, officer, employee or agent of the Company, or arising out of Indemnitee’s status as such, whether or not the
Company would have the power to indemnify Indemnitee against such liability under the provisions of this Agreement or under the
DGCL, as it may then be in effect. The purchase, establishment, and maintenance of any such Indemnification Arrangement shall not
in any way limit or affect the rights and obligations of the Company or of Indemnitee under this Agreement except as expressly
provided herein, and the execution and delivery of this Agreement by the Company and Indemnitee shall not in any way limit or affect
the rights and obligations of the Company or the other party or parties thereto under any such Indemnification Arrangement.

 

     

     

    

 

(c) To the extent that the Company maintains
an insurance policy or policies providing liability insurance for directors, officers, trustees, partners, managers, managing members,
fiduciaries, employees, or agents of the Company or of any other Enterprise which such person serves at the request of the Company,
Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage
available for any such director, officer, trustee, partner, managers, managing member, fiduciary, employee or agent under such
policy or policies. If, at the time the Company receives notice from any source of a Proceeding as to which Indemnitee is a party
or a participant (as a witness, deponent or otherwise), the Company has director and officer liability insurance in effect, the
Company shall give prompt notice of such Proceeding to the insurers in accordance with the procedures set forth in the respective
policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee,
all amounts payable as a result of such Proceeding in accordance with the terms of such policies.

  

(d) In the event of any payment under this
Agreement, the Company, to the fullest extent permitted by law, shall be subrogated to the extent of such payment to all of the
rights of recovery of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including
execution of such documents as are necessary to enable the Company to bring suit to enforce such rights.

  

(e) The Company’s obligation to indemnify,
hold harmless, exonerate or advance Expenses hereunder to Indemnitee who is or was serving at the request of the Company as a director,
officer, trustee, partner, manager, managing member, fiduciary, employee or agent of any other Enterprise shall be reduced by any
amount Indemnitee has actually received as indemnification, hold harmless or exoneration payments or advancement of expenses from
such Enterprise. Notwithstanding any other provision of this Agreement to the contrary except for Article XXVII, (i) Indemnitee
shall have no obligation to reduce, offset, allocate, pursue or apportion any indemnification, hold harmless, exoneration, advancement,
contribution or insurance coverage among multiple parties possessing such duties to Indemnitee prior to the Company’s satisfaction
and performance of all its obligations under this Agreement, and (ii) the Company shall perform fully its obligations under this
Agreement without regard to whether Indemnitee holds, may pursue or has pursued any indemnification, advancement, hold harmless,
exoneration, contribution or insurance coverage rights against any person or entity other than the Company.

 

Article
XVII.

Duration of Agreement

 

All agreements and obligations of the Company
contained herein shall continue during the period Indemnitee serves as a director or officer of the Company or as a director, officer,
trustee, partner, manager, managing member, fiduciary, employee or agent of any other corporation, partnership, joint venture,
trust, employee benefit plan or other Enterprise which Indemnitee serves at the request of the Company and shall continue thereafter
so long as Indemnitee shall be subject to any possible Proceeding (including any rights of appeal thereto and any Proceeding commenced
by Indemnitee pursuant to Article XIV of this Agreement) by reason of Indemnitee’s Corporate Status, whether or not
Indemnitee is acting in any such capacity at the time any liability or expense is incurred for which indemnification or advancement
can be provided under this Agreement.

 

Article
XVIII.

Severability

 

If any provision or provisions of this Agreement
shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a) the validity, legality and enforceability
of the remaining provisions of this Agreement (including, without limitation, each portion of any Article, paragraph or sentence
of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal
or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted
by law; (b) such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law and to give
the maximum effect to the intent of the parties hereto; and (c) to the fullest extent possible, the provisions of this Agreement
(including, without limitation, each portion of any Article, paragraph or sentence of this Agreement containing any such provision
held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to
give effect to the intent manifested thereby.

 

     

     

    

 

Article
XIX.

Enforcement and Binding Effect

 

(a) The Company expressly confirms and agrees
that it has entered into this Agreement and assumed the obligations imposed on it hereby in order to induce Indemnitee to serve
as a director, officer or key employee of the Company, and the Company acknowledges that Indemnitee is relying upon this Agreement
in serving as a director, officer or key employee of the Company.

 

(b) Without limiting any of the rights of
Indemnitee under the Charter or Bylaws of the Company as they may be amended from time to time, this Agreement constitutes the
entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings,
oral, written and implied, between the parties hereto with respect to the subject matter hereof.

 

(c) The indemnification, hold harmless,
exoneration and advancement of expenses rights provided by or granted pursuant to this Agreement shall be binding upon and be enforceable
by the parties hereto and their respective successors and assigns (including any direct or indirect successor by purchase, merger,
consolidation or otherwise to all or substantially all of the business and/or assets of the Company), shall continue as to an Indemnitee
who has ceased to be a director, officer, employee or agent of the Company or a director, officer, trustee, general partner, manager,
managing member, fiduciary, employee or agent of any other Enterprise at the Company’s request, and shall inure to the benefit
of Indemnitee and Indemnitee’s spouse, assigns, heirs, devisees, executors and administrators and other legal representatives.

 

(d) The Company shall require and cause
any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially all or a substantial
part, of the business and/or assets of the Company, by written agreement in form and substance satisfactory to Indemnitee, expressly
to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform
if no such succession had taken place.

 

(e) The Company and Indemnitee agree herein
that a monetary remedy for breach of this Agreement, at some later date, may be inadequate, impracticable and difficult of proof,
and further agree that such breach may cause Indemnitee irreparable harm. Accordingly, the parties hereto agree that Indemnitee
may, to the fullest extent permitted by law, enforce this Agreement by seeking, among other things, injunctive relief and/or specific
performance hereof, without any necessity of showing actual damage or irreparable harm and that by seeking injunctive relief and/or
specific performance, Indemnitee shall not be precluded from seeking or obtaining any other relief to which Indemnitee may be entitled.
The Company and Indemnitee further agree that Indemnitee shall, to the fullest extent permitted by law, be entitled to such specific
performance and injunctive relief, including temporary restraining orders, preliminary injunctions and permanent injunctions, without
the necessity of posting bonds or other undertaking in connection therewith. The Company acknowledges that in the absence of a
waiver, a bond or undertaking may be required of Indemnitee by a court of competent jurisdiction. The Company hereby waives any
such requirement of such a bond or undertaking to the fullest extent permitted by law.

 

Article
XX.

Modification and Waiver

 

No supplement, modification or amendment
of this Agreement shall be binding unless executed in writing by the Company and Indemnitee. No waiver of any of the provisions
of this Agreement shall be deemed or shall constitute a waiver of any other provisions of this Agreement nor shall any waiver constitute
a continuing waiver.

 

     

     

    

 

Article
XXI.

Notices

 

All notices, requests, demands and other
communications under this Agreement shall be in writing and shall be deemed to have been duly given (i) if delivered by hand and
receipted for by the party to whom said notice or other communication shall have been directed, or (ii) mailed by certified or
registered mail with postage prepaid, on the third business day after the date on which it is so mailed:

 

(a) If to Indemnitee, at the address indicated on the signature page
of this Agreement, or such other address as Indemnitee shall provide in writing to the Company. 

  

(b) If to the Company, to:

  

RMG Acquisition Corp.

1411 Broadway, 16th Floor

New York, NY 10018

Attention: Robert S. Mancini

 

With a copy, which shall not constitute notice, to:

 

Latham & Watkins LLP 

811 Main Street, Suite 3700

Houston, Texas 77002 

Attn: Ryan J. Maierson 

Fax No.: (713) 546-5401

 

or to any other address as may have been furnished to Indemnitee
in writing by the Company.

  

Article
XXII.

Applicable Law and Consent to Jurisdiction

 

This Agreement and the legal relations among
the parties shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware, without regard
to its conflict of laws rules. Except with respect to any arbitration commenced by Indemnitee pursuant to Article XIV(a)
of this Agreement, to the fullest extent permitted by law, the Company and Indemnitee hereby irrevocably and unconditionally: (a)
agree that any action or proceeding arising out of or in connection with this Agreement shall be brought only in the Delaware Court
and not in any other state or federal court in the United States of America or any court in any other country; (b) consent to submit
to the exclusive jurisdiction of the Delaware Court for purposes of any action or proceeding arising out of or in connection with
this Agreement; (c) waive any objection to the laying of venue of any such action or proceeding in the Delaware Court; and (d)
waive, and agree not to plead or to make, any claim that any such action or proceeding brought in the Delaware Court has been brought
in an improper or inconvenient forum, or is subject (in whole or in part) to a jury trial. To the fullest extent permitted by law,
the parties hereby agree that the mailing of process and other papers in connection with any such action or proceeding in the manner
provided by Article XXI or in such other manner as may be permitted by law, shall be valid and sufficient service thereof.

 

Article
XXIII.

Identical Counterparts

 

This Agreement may be executed in one or
more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute
one and the same Agreement. Only one such counterpart signed by the party against whom enforceability is sought needs to be produced
to evidence the existence of this Agreement.

 

Article
XXIV.

Miscellaneous

 

Use of the masculine pronoun shall be deemed
to include usage of the feminine pronoun where appropriate. The headings of the paragraphs of this Agreement are inserted for convenience
only and shall not be deemed to constitute part of this Agreement or to affect the construction thereof.

 

     

     

    

 

Article
XXV.

Period of Limitations

 

No legal action shall be brought and no
cause of action shall be asserted by or in the right of the Company against Indemnitee, Indemnitee’s spouse, heirs, executors
or personal or legal representatives after the expiration of two (2) years from the date of accrual of such cause of action, and
any claim or cause of action of the Company shall be extinguished and deemed released unless asserted by the timely filing of a
legal action within such two (2)-year period; provided, however, that if any shorter period of limitations is otherwise applicable
to any such cause of action such shorter period shall govern.

 

Article
XXVI.

Additional Acts

 

If for the validation of any of the provisions
in this Agreement any act, resolution, approval or other procedure is required to the fullest extent permitted by law, the Company
undertakes to cause such act, resolution, approval or other procedure to be affected or adopted in a manner that will enable the
Company to fulfill its obligations under this Agreement.

 

Article
XXVII.

Waiver of Claims to Trust Account

 

Indemnitee hereby agrees that it does not
have any right, title, interest or claim of any kind (each, a “Claim”) in or to any monies in the trust account
established in connection with the Company’s initial public offering for the benefit of the Company and holders of shares
issued in such offering, and hereby waives any Claim it may have in the future as a result of, or arising out of, any services
provided to the Company and will not seek recourse against such trust account for any reason whatsoever.

 

Article
XXVIII.

Maintenance
of Insurance

 

The Company shall use commercially reasonable
efforts to obtain and maintain in effect during the entire period for which the Company is obligated to indemnify the Indemnitee
under this Agreement, one or more policies of insurance with reputable insurance companies to provide the officers and directors
of the Company with coverage for losses from wrongful acts and omissions and to ensure the Company’s performance of its indemnification
obligations under this Agreement. The Indemnitee shall be covered by such policy or policies in accordance with its or their terms
to the maximum extent of the coverage available for any such director or officer under such policy or policies. In all such insurance
policies, the Indemnitee shall be named as an insured in such a manner as to provide the Indemnitee with the same rights and benefits
as are accorded to the most favorably insured of the Company’s directors and officers.

 

[Signature Page Follows]

 

     

     

    

 

IN WITNESS WHEREOF, the parties hereto have
caused this Indemnity Agreement to be signed as of the day and year first above written.

 

	 	
        

        RMG ACQUISITION CORP.
	 
	 	 	 
	 	 	 	 
	 	By:	/Robert S. Mancini	 
	 	Name:	Robert S. Mancini	 
	 	Title:	Chief Executive Officer	 

 

 

[Signature page to Indemnity Agreement]

  

     

     

    

 

	 	INDEMNITEE:	 
	 	 	 	 	 
	 	 	 	 	 
	 	By:	/s/ Steven Buffone	 
	 	Name:	Steven Buffone	 

 

  

[Signature page to Indemnity Agreement]Exhibit 10.1

  

   

    

  
    Execution Version

    

    

    CITIGROUP GLOBAL MARKETS INC.

    

    388 GREENWICH STREET

    NEW YORK, NY 10013

     

    February 5, 2020

     

    Science Applications International Corporation

    12010 Sunset Hills Rd

    Reston, VA  20190

    

    

    Attention:  Charles A. Mathis

     

    Commitment Letter

    Term Loan B Incremental Facility

    Senior Unsecured Bridge Facility

    

    

    Ladies and Gentlemen:

     

    Science Applications International Corporation, a Delaware corporation (the “Company” or “you”), has advised Citi (as defined below) (“Commitment Party” and, collectively, the “Commitment Parties”,
      “we” or “us”) that the Company
      desires to consummate the Transactions (as defined in Exhibit A hereto (such exhibit, the “Transactions Description”)).  Capitalized terms
      used in this letter agreement but not defined herein shall have the meanings given to them in the Exhibits (as defined below) hereto.  For the purposes of this Commitment Letter and the Fee Letter referred to below, “Citi” shall mean Citigroup Global Markets Inc. (“CGMI”),
      Citibank, N.A., Citicorp USA, Inc., Citicorp North America, Inc. and/or any of their affiliates as Citi shall determine to be appropriate to provide the services contemplated herein.

     

    Upon the terms and subject to the conditions described in this letter
        agreement and the attached Exhibit A, Exhibit B, Exhibit C, Exhibit D and Exhibit E (collectively, the “Exhibits” and, together with this letter agreement, this “Commitment
        Letter”), Citi is pleased to inform the Company of Citi’s commitment to provide the entire aggregate principal amount of the Term Loan B Incremental Facility (as
      defined in Exhibit A) and the Bridge Facility (as defined in Exhibit A) (Citi, in such capacity, an “Initial Lender”).

     

    Section 1.             Title and Roles.

     

    You hereby appoint Citi to act, and Citi hereby agrees to act, as (x) a joint bookrunner and joint lead arranger with respect to the Term Loan B
      Incremental Facility (together with any other agents, co-agents, joint bookrunners or joint lead arrangers appointed pursuant to the following paragraph, each in such capacity, a “Bank Arranger”
      and, collectively in such capacities, the “Bank Arrangers”), (y) a joint bookrunner and a joint lead arranger with respect to the Bridge Facility (together with any other agents, co-agents, managers, co-managers, or joint lead arrangers appointed pursuant to the following
      paragraph, each in such capacity, a “Bridge Arranger”, collectively in such capacities, the “Bridge Arrangers” and together with the Bank Arrangers, an “Arranger”, collectively in such capacities, the “Arrangers”) and (z) as sole administrative
      agent with respect to the Bridge Facility, in each case upon the terms and subject to the conditions described in this Commitment Letter.

     

    
      
        

    

    
    You agree that no additional agents, co-agents, bookrunners or lead arrangers will be appointed, or other titles conferred, and no compensation (other
      than that expressly contemplated by this Commitment Letter and the Fee Letter referred to below) will be paid to any other person in order to obtain commitments to the Facilities (as defined in Exhibit A) unless you and the Commitment Parties shall
      so agree; provided that you may, on or prior to the date that is 15 days after the date hereof, appoint up to an aggregate of six additional agents,
      co-agents, joint bookrunners or joint lead arrangers (other than administrative or collateral agents) and an unlimited number of co-managers, in each case in a manner and with economics set forth in the immediately succeeding proviso (it being
      understood and agreed that, to the extent you appoint any additional agents, co-agents, joint bookrunners, joint lead arrangers or co-managers in respect of the Facilities, then, notwithstanding anything herein to the contrary, the commitments of
      Citi as of the date hereof in respect of the applicable Facilities will be permanently reduced by the amount of the commitments of such appointed entities (or their relevant affiliates) in respect of each of the applicable Facilities upon the
      execution by such financial institution (and any relevant affiliate) of a customary amended and restated commitment letter and fee letter (or joinders thereto) in form and substance acceptable to you and us and, thereafter, each such financial
      institution (and any relevant affiliate) shall constitute an “Arranger” and it or its relevant affiliate providing such commitment shall
      constitute a “Commitment Party” and the commitments of the Commitment Parties in respect of the applicable Facilities shall be several and
      not joint); provided, further, that, in connection with the
      appointment of any additional agents, co-agents, joint bookrunners, joint lead arrangers or co-managers (each, an “Additional Agent”) for the
      Facilities in accordance with the immediately preceding proviso, (i) the aggregate economics payable to all such additional agents, co-agents, joint bookrunners, joint lead arrangers and co-managers and their respective affiliates in respect of the
      Facilities shall not exceed 65.0% of the total economics which would be payable to Citi as of the date hereof in respect of the Facilities pursuant to the Fee Letter and if no additional agents, co-agents, joint bookrunners, joint lead arrangers or
      co-managers are appointed by you, Citi shall retain all of the economics with respect to the Facilities, (ii) no agent, co-agent, joint bookrunner, joint lead arranger or co-manager (or any affiliate thereof) so appointed by you shall receive
      economics greater than the economics in respect of the Facilities to be received by Citi as of the date hereof under the Fee Letter, (iii) each additional agent, co-agent, joint bookrunner, joint lead arranger and co-manager (or its relevant
      affiliate) so appointed by you shall provide commitments ratably across each of the Term Loan B Incremental Facility and the Bridge Facility, (iv) the aggregate economics payable to any such additional agent, co-agent, joint bookrunner, joint lead
      arranger or co-manager (or any relevant affiliate thereof) in respect of the Facilities shall be proportionate to the commitment of such additional agent, co-agent, joint bookrunner, joint lead arranger or co-manager (or any relevant affiliate
      thereof), (v) it is understood and agreed that any such additional agents, co-agents, joint bookrunners, joint lead arrangers and co-managers shall not be physical bookrunners and that Citi will have primary authority for managing the syndication of
      the Facilities and (vi) it is further understood and agreed that Citi shall have “left side” placement in any and all marketing materials or other documentation used in connection with the Facilities and shall hold the leading role and responsibilities conventionally associated with such “left” placement.

     

    Section 2.             Syndication.

     

    The Commitment Parties reserve the right,
        prior to and/or after the execution of the definitive documentation (including the incremental facilities amendment to the Existing Credit Agreement and any additional security agreements, ancillary agreements, certificates or other documents
        delivered in connection therewith) with respect to the Facilities (collectively, the “Operative Documents”), to syndicate all or a portion of
        their commitments under the Facilities to one or more other banks, financial institutions, investors and other lenders identified by us in
        consultation with you and subject to your consent (such consent not to be unreasonably withheld, conditioned or delayed) (the lenders providing the Facilities, together with the Initial Lenders, collectively referred to herein as the “Lenders”); provided that we agree not to syndicate our commitments to (i) certain banks, financial institutions, investors, other institutional lenders and other entities
        (including, without limitation, any competitor of the Company or any of its respective affiliates or subsidiaries), in each case, identified by name in writing to us prior to the date hereof, (ii) any affiliates of the persons identified under
        clause (i) above that are either known by us to be such affiliates or are readily identifiable as such by their name, and (iii) any natural person (such persons, collectively, the “Disqualified Institutions”) and that none of the Disqualified
        Institutions may become a Lender or participant in respect of any of the Facilities.  Subject to the foregoing, Citi will manage all aspects of
        the syndication of the Facilities in consultation with the Company, including the timing of the commencement of syndication efforts, the timing of
        all offers to potential Lenders, the determination of all amounts offered to potential Lenders, the selection of Lenders and the allocation of commitments among the Lenders.  Notwithstanding any other provision of this Commitment Letter to
      the contrary and notwithstanding any syndication, assignment or other transfer by us, (a) except in case of any assignment to an Additional Agent, we shall not be released or novated from our obligations hereunder (including our obligation to fund
      our applicable percentage of the Facilities on the Closing Date (as defined below)) and no syndication, assignment or other transfer thereof shall become effective until after the initial funding of the Facilities on the Closing Date (or, to the
      extent funded into escrow prior to the Closing Date, the deposit of the proceeds of such Facilities into escrow), and (b) unless you agree in writing, we will retain exclusive control over all rights and obligations with respect to our commitments
      and other obligations in respect of the Facilities, including all rights with respect to consents, waivers, modifications, supplements and amendments, until the Closing Date has occurred.

     

    

    
      2

      
        

    

    Without limiting your obligations to assist with syndication efforts as
        set forth herein, it is understood that our commitments hereunder are not conditioned upon the syndication of, or receipt of commitments in respect of, the Facilities and in no event shall the commencement or successful completion of syndication of the Facilities, nor the obligation to assist with syndication
        efforts as set forth herein, constitute a condition to the commitment hereunder or the funding of the Facilities on the Closing Date.  The Arrangers may commence
        syndication efforts promptly upon the execution of this Commitment Letter and as part of their syndication effort, and without limiting anything contained in the last sentence of the immediately preceding paragraph, it is the Arrangers’ intent to
        have Lenders commit to the Facilities prior to the Closing Date.  Until the earlier of (i) the 60th day following the date of the consummation of the Acquisition
      (as defined in Exhibit A) with the proceeds of the initial funding under the Term Loan B Incremental Facility (the date of such consummation and funding, the “Closing Date”), and (ii) the date upon which a Successful Syndication (as defined in the Fee Letter) is achieved (such earlier date, the “Syndication Date”), the Company hereby agrees to use its commercially reasonable
        efforts to assist us in achieving a syndication that is reasonably satisfactory to us and you.  The Company’s assistance in achieving such syndication shall include but not be limited to:  (i) making appropriate members of the senior management,
        representatives and non-legal advisors of the Company (and, to the extent not in contravention of the Acquisition Agreement (as defined in Exhibit A) using its commercially reasonable efforts to make appropriate members of the senior management,
        representatives and non-legal advisors of the Transferred Assets (as defined in the Acquisition Agreement) (together with all related business operations and employees, the “Acquired Business”) available to participate in informational meetings with potential Lenders and/or
        ratings agencies at such times and places to be mutually agreed (or, if you and we shall agree, conference calls in lieu of any such meeting); (ii) using its commercially reasonable efforts to ensure that the syndication efforts benefit from the
        existing lending relationships of the Company; (iii) assisting (including, using its commercially reasonable efforts to cause its affiliates and non-legal advisors, and to the extent not in contravention of the Acquisition Agreement, the Acquired
        Business and its affiliates and non-legal advisors, to assist) in the preparation (and/or providing to us) of a customary confidential information memorandum for the Facilities, other customary marketing materials and any other information reasonably requested by the Arrangers with respect to the Company and its subsidiaries, the Acquired Business or the Transactions in connection with the syndication
        (collectively, the “Company Materials”)
        and using its commercially reasonable efforts to ensure that the Arrangers shall have received no later than 20 business days prior to the Closing Date all necessary information to complete the confidential information memorandum (including
        executed customary authorization letters in respect thereof that include a customary “10b-5” representation); (iv) the hosting, with the Arrangers, of a reasonable number of meetings or conference calls of prospective Lenders; (v) using its
        commercially reasonable efforts (A) to procure an updated rating for the Existing Credit Agreement and a rating for the Term Loan B Incremental Facility and the Notes (as defined in Exhibit A) by Moody’s Investors Service, Inc. (“Moody’s”) and Standard & Poor’s Rating Services (“S&P”) no later than 20 business days prior to the Closing Date (but no specific rating) and (B) to
        maintain a corporate family rating or corporate rating, as applicable, of the Company from each of Moody’s and S&P (but no specific rating) and (vi) delivering to the Arrangers, promptly upon receipt thereof, all financial information related
        to the Acquired Business delivered to the Company pursuant to the Acquisition Agreement.

     

    
      3

      
        

    

    The Company acknowledges that (i) the Arrangers may make available the
        Company Materials on a confidential basis to potential Lenders by posting the Company Materials on Intralinks, SyndTrak Online, Debtdomain, the internet, email and/or similar electronic transmission systems (the “Platform”) and (ii) certain of the potential Lenders may be public
        side Lenders (i.e., Lenders that do not wish to receive
        material non-public information with respect to you, your subsidiaries, the Acquired Business or any securities of any thereof) (each, a “Public Lender”).  The Company agrees that (A) at the request of any Arranger, it will assist us in preparing a version of the information package
        and presentation to be provided to potential Lenders that does not contain any material non-public information concerning you, your subsidiaries, Seller (as defined in the Acquisition Agreement) (the “Seller”), the Acquired Business or any securities of any thereof for
        purposes of United States federal and state securities laws (any such information, “MNPI”, and any information package or presentation that contains MNPI is referred to as “Private-Side Materials”); (B) all Company Materials that are Private-Side Materials will be clearly and conspicuously marked “Private, contains
        Material Non-Public Information” which will mean that “Private, contains Material Non-Public Information” will appear prominently on the first page thereof; (C) if any Company Materials are not marked, the Company will be deemed to have authorized
        the Arrangers and the proposed Lenders to treat such Company Materials as not containing any MNPI; (D) all Company Materials not marked “Private, contains Material Non-Public Information” are permitted to be made available through a portion of the
        Platform designated “Public Lender” and (E) the Company shall provide us with customary authorization letters for inclusion in the Company Materials that represents that any Company Materials not marked “Private, contains Material Non-Public
        Information” does not include MNPI and will contain customary language exculpating us with respect to any liability related to the use or misuse of the contents of the Company Materials by the recipients thereof.  The Arrangers agree to treat any
        Company Materials that are marked “Private, contains Material Non-Public Information” as being suitable only for posting on a portion of the Platform not designated “Public Lender”.  To ensure an orderly and effective syndication of each Facility, the Company agrees that, until the Syndication Date, the Company will not, and will not permit any of its subsidiaries to (and the Company will use commercially reasonable
        efforts to not permit the Acquired Business to), syndicate, issue, place, arrange or attempt to syndicate, issue, place or arrange, or announce or authorize the announcement of the syndication, issuance, placement or arrangement of, any debt
        facility or debt security (including, without limitation, the renewal of any thereof, but excluding the Facilities and the Notes, any additional borrowing under
        the Revolving Credit Facility (as defined in the Existing Credit Agreement), any sale of receivables to the extent the same could be deemed to be a secured financing, and any ordinary course capital leases, purchase money indebtedness, equipment
        financings, letters of credit or surety bonds) without the prior written consent of the Arrangers if such syndication, issuance, placement or arrangement could reasonably be expected to impair the primary syndication of the Facilities or
      placement of the Notes.

     

    Section 3.             Conditions.

     

    The commitments of each Commitment Party hereunder to fund its respective portion of the Facilities on the Closing Date and the agreements of each of
      the Arrangers to perform the services described herein are subject solely to the satisfaction (or waiver by each of the Commitment Parties) of the following conditions
        precedent:  (a) since September 30, 2019, there shall not have occurred any Material Adverse Effect (as defined below), (b) subject to the Limited Conditionality Provisions (as defined below), the execution and delivery of the respective Operative
        Documents by the Company and the Guarantors (as defined in Exhibit B) on the terms set forth in this Commitment Letter and with respect to any terms not specifically set forth herein, on terms reasonably satisfactory to the Company and the
        Arrangers, (c) solely with regards to the Term Loan B Incremental Facility, the satisfaction of the conditions set forth in Section 2.23(b)(ii) of the Existing Credit Agreement as in effect on the date hereof and (d) the satisfaction (or waiver by
        each of the Commitment Parties) of the other conditions set forth in Exhibit D hereto (clauses (a), (b), (c) and (d)), collectively, the “Funding Conditions”); it being understood that there are no conditions (implied or otherwise) to the commitments hereunder other than the Funding
        Conditions (and upon satisfaction or waiver of the Funding Conditions, the initial funding under the Facilities shall occur).  For purposes of this Commitment
        Letter, “Material Adverse Effect”
        shall have the meaning in the Acquisition Agreement (as in effect on the date hereof).

     

    
      4

      
        

    

    Notwithstanding anything set forth in this Commitment Letter, the Fee Letter or the Operative Documents, or any other letter agreement or other
      undertaking concerning the financing of the Transactions to the contrary, (i) the only representations and warranties, the accuracy of which shall be a condition to availability of the Facilities on the Closing Date, shall be (x) such of the
      representations and warranties made by or on behalf of the Seller in the Acquisition Agreement as are material to the interests of the Lenders or the Arrangers (in their capacities as such), but only to the extent that you (or any of your affiliates)
      have the right to terminate your (or its) obligations (or to refuse to consummate the Acquisition) under the Acquisition Agreement as a result of a breach of any of such representations and warranties (to such extent, the “Acquisition Agreement Representations”) and (y) the Specified Representations (as defined in the Existing Credit Agreement as in effect on the date hereof) made by the Company and Guarantors in the Operative Documents and (ii) the terms of the Operative Documents shall be in a form such that they do not impair the
      availability of the Facilities on the Closing Date if the Funding Conditions are satisfied or waived (it being understood that to the extent any Collateral (as defined in
        Exhibit B) (other than Collateral in which a security interest therein may be perfected by (A) the filing of a Uniform Commercial Code financing statement, (B) taking delivery and possession of stock (or other equity interest) certificates
      and related stock powers executed in blank (other than in respect of any immaterial or non-wholly owned subsidiary (to be defined in a manner to be reasonably agreed) of the Acquired Business organized outside of the United States) or (C) the filing
      of a short form security agreement with the United States Patent and Trademark Office or the United States Copyright Office) cannot be delivered or a security interest therein cannot be created or perfected on the Closing Date after your use of commercially reasonable efforts to do so, then the creation and/or perfection of the security interest in such Collateral shall not constitute a condition precedent to
        the availability of the Term Loan B Incremental Facility on the Closing Date but, instead, may be accomplished pursuant to arrangements and timing to be
        reasonably and mutually agreed by the parties hereto acting reasonably (with extensions available in the Term Loan B Agent’s (as defined in Exhibit B) reasonable discretion). The provisions of this paragraph are referred to as the “Limited Conditionality Provisions”.

     

    Section 4.             Commitment Termination.

     

    Each Commitment Party’s commitment hereunder and the other obligations set forth in this Commitment Letter will terminate on the earliest of:  (a) the
      consummation of the Acquisition with or without the funding of the Facilities; (b) August 5, 2020 and (c) the date the Acquisition Agreement is terminated. Notwithstanding anything herein to the contrary, the Company may not terminate commitments
      with regards to the Bridge Facility unless all commitments to the Bridge Facility have been terminated.

     

    
      5

      
        

    

    Section 5.             Fees.

     

    As consideration for our commitments and other obligations hereunder and our agreement to perform the services described herein, you agree to pay (or
      to cause to be paid) to us the fees set forth in this Commitment Letter and in the arranger fee letter dated the date hereof among the parties hereto (such fee letter, as amended, amended and restated, supplemented or otherwise modified, the “Fee Letter”).  The terms of the Fee Letter are an integral part of our commitments and other obligations hereunder and our agreement to perform
      the services described herein and constitute part of this Commitment Letter for all purposes hereof.  Each of the fees described in this Commitment Letter and the Fee Letter shall be nonrefundable when paid except as expressly set forth therein.

     

    Section 6.             Indemnification.

     

    The Company shall indemnify and hold harmless each Commitment Party, its affiliates, and each Commitment Party’s and such affiliates’
      respective directors, controlling persons, officers, employees, agents, trustees, representatives, attorneys, consultants and advisors (each, an “Indemnified Person”) from and against any and all claims (including, without limitation, shareholder actions), damages, losses, liabilities and expenses (including, without limitation, reasonable and documented out-of-pocket fees
      and disbursements of counsel but limited, in the case of legal fees and disbursements, to one counsel to such Indemnified Persons, taken as a whole, and, solely in the case of an actual or potential conflict of interest, one additional counsel to
      each set of similarly affected Indemnified Persons, taken as a whole (and, if reasonably necessary, of one local counsel in any relevant jurisdiction to all such persons, taken as a whole and, solely in the case of any such actual or potential
      conflict of interest one additional counsel of the applicable type to each set of similarly affected Indemnified Persons)), that may be incurred by or
        asserted or awarded against any Indemnified Person (including, without limitation, in connection with or relating to any investigation, litigation or proceeding or the preparation of a defense in connection therewith), in each case arising out of
        or in connection with or by reason of this Commitment Letter, the Fee Letter or the Operative Documents, or the transactions contemplated hereby or thereby or any use of the proceeds thereof (any of the foregoing, a “Proceeding”), except to the extent
        such claim, damage, loss, liability or expense is (i) found in a final non-appealable judgment by a court of competent jurisdiction to have resulted from such Indemnified Person’s or its controlled affiliate’s bad faith, gross negligence or willful
        misconduct or material breach of this Commitment Letter or the Fee Letter or (ii) the result of any Proceeding that is not the result of an act or omission by you or any of your affiliates and that is brought by an Indemnified Person against any
        other Indemnified Person (other than any claims against any Commitment Party in its capacity or in fulfilling its role as Arranger, administrative agent, collateral agent or any similar role under the Existing Credit Agreement or the Facilities, as applicable).  In the case of an investigation, litigation or other proceeding to which the indemnity in this paragraph applies, such indemnity shall be
        effective whether or not such investigation, litigation or proceeding is brought by the Company, any of its directors, security holders or creditors, an Indemnified Person or any other person, or an Indemnified Person is otherwise a party thereto
        and whether or not the Transactions are consummated.

    

    

    In no event shall any party hereto be liable on any theory of liability for any special, indirect, consequential or punitive damages (including,
      without limitation, any loss of profits, business or anticipated savings); provided that nothing contained in this paragraph shall limit your indemnity and
      reimbursement obligations for such damages awarded to third parties to the extent set forth in the immediately preceding paragraph.

     

    You shall not be liable for any settlement of any Proceeding effected without your written consent (which consent shall not be unreasonably withheld,
      conditioned or delayed), but if settled with your written consent or if there is a judgment in any such Proceeding, you agree to indemnify and hold harmless each Indemnified Person from and against any and all losses, claims, damages, liabilities and
      expenses by reason of such settlement or judgment in accordance with the other provisions of this Section 6.

     

    

    
      6

      
        

    

    You agree that, without our prior written consent, neither you nor any of your subsidiaries will settle, compromise or consent to the entry of any
      judgment in any pending or threatened claim, action or proceeding in respect of which indemnification could be sought under the indemnification provision of this Commitment Letter (whether or not we or any other Indemnified Person is an actual or
      potential party to such claim, action or proceeding), unless such settlement, compromise or consent includes an unconditional release of each Indemnified
      Person from all liability arising out of such claim, action or proceeding and does not include a statement as to or an admission of fault, culpability or failure to act by or on behalf of any Indemnified Person.

     

    The Company acknowledges that information and other materials relative to the Operative Documents and the Transactions may be transmitted through the
      Platform.  No Indemnified Person will be liable to the Company or any of its affiliates or any of its security holders or creditors or any other person for any damages arising from the use or misuse by persons of information or other materials sent
      through the Platform, except to the extent such liability is determined by a final non-appealable judgment by a court of competent jurisdiction to have resulted from such Indemnified Person’s or its controlled affiliate’s bad faith, gross negligence
      or willful misconduct or material  breach of this Commitment Letter.

     

    Section 7.             Costs and Expenses.

     

    The Company shall pay, or reimburse the Commitment Parties on the earlier to occur of (i) the Closing Date and (ii) the date of the termination or
      expiration of the commitments under this Commitment Letter (and thereafter, if applicable, on demand) for, all reasonable and documented out-of-pocket costs and expenses incurred by the Commitment Parties in connection with the Facilities and the
      preparation, negotiation, execution and delivery of this Commitment Letter, the Fee Letter and the Operative Documents, including, without limitation, the reasonable fees, disbursements and other charges of one counsel to the Commitment Parties,
      taken as a whole (and, if reasonably necessary, of one local counsel in any relevant jurisdiction to the Commitment Parties, taken as a whole), regardless of whether any of the transactions contemplated hereby is consummated.  The Company shall also
      pay all reasonable and documented out-of-pocket costs and expenses of the Commitment Parties (including, without limitation, the reasonable fees, disbursements and other
        charges of one counsel to the Commitment Parties, taken as a whole (and, if reasonably necessary, of one local counsel in any relevant jurisdiction to the Commitment Parties, taken as a whole)) incurred in connection with the enforcement of any of
        their rights and remedies hereunder.

     

    Section 8.             Confidentiality.

     

    The Company agrees that this Commitment Letter and the Fee Letter are for its confidential use only and that neither their existence nor the terms hereof or thereof will be disclosed by it to any person other than its subsidiaries and the officers, directors, employees, managers, members, partners, accountants,
        attorneys and other advisors of the Company and its subsidiaries, and then only on a confidential and “need to know” basis in connection with the transactions contemplated hereby; provided, however, that the Company may disclose this Commitment Letter and the contents hereof and, to the extent specified below, the Fee Letter and the contents thereof:  (a) (i) as may be
        compelled in a judicial or administrative proceeding or in any proceeding or pursuant to the order of any court or administrative agency or upon the request or demand of any regulatory authority or (ii) as otherwise required by law or in any
        required filings with the Securities and Exchange Commission and to the extent required by applicable regulatory authorities or stock exchanges (but with respect to this clause (ii) in the case of the Fee Letter and the contents thereof,  so long
        as the actual fees and “market flex” provisions are redacted from the Fee Letter in a manner reasonably satisfactory to the Arrangers); (b) as part of generic disclosure of aggregate sources and uses with respect to the Transactions; (c) to Moody’s
        or S&P in connection with obtaining a rating of the Facilities (but in the case of the Fee Letter and the contents thereof, only as part of generic
        disclosure of aggregate sources and uses with respect to the Transactions); (d) to the Seller, the Acquired Business and their respective subsidiaries and controlling persons and the officers, directors, employees, managers, members, partners,
        accountants, attorneys and other advisors of any of the foregoing who are directly involved in the consideration of this matter, in each case on a confidential and “need to know” basis in connection with the transactions contemplated hereby (but in
        the case of the Fee Letter and the contents thereof, only as part of generic disclosure of aggregate sources and uses with respect to the Transactions); (e) in syndication or other marketing materials relating to the Facilities (but not the Fee Letter or the contents thereof, except as part of generic disclosure of aggregate sources and uses with respect to the Transactions), (f) with our prior
        written consent or (g) to any Additional Agent on a confidential basis.

     

    
      7

      
        

    

    Each Commitment Party, on behalf of itself and its affiliates, agrees that it will use all confidential information provided to it or its affiliates
      by or on behalf of you hereunder solely for the purpose of providing the services which are the subject of this Commitment Letter and shall treat confidentially all such information; provided that nothing herein shall prevent any Commitment Party from disclosing any such information (a) pursuant to the order of any court or administrative agency or otherwise as required by applicable law or
      regulation or as requested by a governmental authority (in which case such Commitment Party, to the extent permitted by law and except with respect to any audit or examination conducted by bank accountants or any governmental bank authority
      exercising examination or regulatory authority, agrees to inform you promptly thereof), (b) upon the request or demand of any regulatory authority having jurisdiction over such Commitment Party or any of its affiliates, (c) to the extent that such
      information becomes publicly available other than by reason of disclosure by any Commitment Party in violation of this paragraph, (d) to the extent that such information is received by any Commitment Party from a third party that is not, in each case
      to such Commitment Party’s knowledge, (i) in such third party’s possession illegally or (ii) subject to confidentiality obligations to you, your subsidiaries or the Seller, (e) to the extent that such information is independently developed by any
      Commitment Party, (f) to any of the Commitment Parties’ affiliates and any of their respective employees, legal counsel, independent auditors and other experts or agents who need to know such information in connection with the Facilities and are
      informed of the confidential nature of such information, (g) to prospective Lenders, participants or assignees of obligations under the Facilities (other than any Disqualified Institution), in each case who agree to be bound by the terms of this
      paragraph (or language substantially similar to this paragraph), (h) to Moody’s or S&P in connection with obtaining a rating of the Facilities in consultation and coordination with you, (i) for the purposes of establishing a “due diligence” or
      other appropriate defense, (j) to any Additional Agent or prospective Additional Agent or (k) to any prospective purchaser in connection with the marketing of the Notes.  The Commitment Parties’ obligations under this paragraph shall automatically terminate and be superseded by the confidentiality provisions in the Operative Documents upon the execution and delivery thereof and, in the event the Operative Documents
        have not been executed and delivered, shall expire on the date occurring 24 months after the date hereof.

     

    You acknowledge that neither any of the Commitment Parties nor any of their affiliates provide accounting, tax or legal advice.  You further
      acknowledge that the Commitment Parties and their affiliates may be providing debt financing, equity capital or other services (including, without limitation, financial advisory services) to other persons in respect of which you, the Seller, the
      Acquired Business and your and their respective affiliates may have conflicting interests regarding the transactions described herein and otherwise.  You also acknowledge that none of the Commitment Parties or their affiliates has any obligation to
      use in connection with the transactions contemplated by this Commitment Letter, or to furnish to you, confidential information obtained by them from other persons.  As you know, the Commitment Parties are full service securities firms engaged, either
      directly or through their affiliates, in various activities, including securities trading, commodities trading, investment management, financing and brokerage activities and financial planning and benefits counseling for both companies and
      individuals.  In the ordinary course of these activities, the Commitment Parties and their respective affiliates actively engage in commodities trading or trade the debt and equity securities (or related derivative securities) and financial
      instruments (including bank loans and other obligations) of the Company and other companies which may be the subject of the arrangements contemplated by this Commitment Letter for their own account and for the accounts of their customers and may at
      any time hold long and short positions in such securities.  The Commitment Parties or their affiliates also co-invest with, make direct investments in, and invest or co-invest client monies in or with funds or other investment vehicles managed by
      other parties, and such funds or other investment vehicles may trade or make investments in securities of you, the Seller, the Acquired Business or other companies which may be the subject of the arrangements contemplated by this Commitment Letter or
      engage in commodities trading with any thereof.

     

    
      8

      
        

    

    In addition, you acknowledge that you have retained Citi as financial advisor (in such capacity, the “Financial Advisor”) in connection with the Acquisition.  You agree not to assert any claim you might allege based on any actual or potential conflicts of interest that might be
      asserted to arise or result from, on the one hand, the engagement of the Financial Advisor and, on the other hand, our and our affiliates’ relationships with you as described and referred to herein.

     

    Section 9.             Representations and Warranties.

     

    The Company represents and warrants (which representation and warranty, in the case of any information relating to the Acquired Business prior to the
      Acquisition, is to the best of the Company’s knowledge) that (i) all written information, other than Projections (as defined below), other forward-looking information and information of a general economic or industry-specific nature, that has been or
      will hereafter be made available to any of the Commitment Parties or any Lender by or on behalf of the Company, the Acquired Business or any of their respective representatives in connection with the Transactions (the “Information”) is and will be, when furnished, true and correct in all material respects and does not and will not, taken as a whole, contain any untrue statement of a
      material fact or omit to state a material fact necessary in order to make the statements contained therein not materially misleading in light of the circumstances under which such statements were or are made (after giving effect to all supplements
      and updates thereto provided prior to the later of the Closing Date and the Syndication Date) and (ii) all financial projections, if any, that have been or will be prepared by or on behalf of the Company or any of its representatives and made
      available to any of the Commitment Parties, any Lender or any potential Lender (the “Projections”) have been or will be prepared in good
      faith based upon assumptions that are believed by you to be reasonable at the time made and at the time the related financial projections are made available (it being understood that such Projections are as to future events and are not to be viewed as facts, that actual results during the period or periods covered by any such Projections may differ significantly from the projected results and that such
        differences may be material, that such Projections are subject to significant uncertainties and contingencies many of which are beyond your control, and that no assurance can be given that the projected results will be realized).  If, at any time
        from the date hereof until the later of the Closing Date and the Syndication Date, you become aware that any of the representations and warranties in the preceding sentence would be incorrect in any material respect if the Information or
        Projections were being furnished, and such representations and warranties were being made, at such time, then you agree to (or, with respect to any such Information or Projections relating to the Acquired Business or its operations or assets, use
        your commercially reasonable efforts to cause the Seller to) promptly supplement the Information and/or Projections so that (and with respect to Information or Projections relating to the Acquired Business or its operations or assets, to the best
        of your knowledge) the representations and warranties contained in this paragraph remain true and correct in all material respects under those circumstances.  For the avoidance of doubt, our commitments hereunder and the funding of the Facilities on the Closing Date are not conditioned upon the accuracy of the representations made in this Section 9.

     

    
      9

      
        

    

    In arranging and syndicating the Facilities, the Commitment Parties will be entitled to use, and to rely on the representations and warranties in the
      preceding paragraph relating to, any information furnished to us by or on behalf of the Company and its affiliates without responsibility for independent verification thereof.

     

    Section 10.           Assignments.

     

    The Company may not assign or delegate any of its rights or obligations under this Commitment Letter or the Fee Letter without our prior written
      consent, and any attempted assignment without such consent shall be null and void.  No Commitment Party may assign or delegate any of its rights or obligations under this Commitment Letter or its commitment hereunder (except to one or more of its
      affiliates; provided that any assignments to an affiliate will not relieve a Commitment Party from any of its obligations hereunder unless and until such affiliate shall
      have funded the portion of the commitment so assigned) other than as expressly permitted hereunder without the Company’s prior written consent, and any attempted assignment or delegation without such consent shall be null and void.

     

    Section 11.           Amendments.

     

    Neither this Commitment Letter nor the Fee Letter may be amended or any provision hereof waived or modified except by an instrument in writing signed
      by each party hereto or thereto, as applicable.

     

    Section 12.           Governing Law, Etc.

     

    This Commitment Letter (and any claim, controversy or dispute arising under or related to any of the foregoing, whether based on contract, tort or otherwise) shall be
      governed by, and construed in accordance with, the law of the State of New York, without giving effect to any conflicts of law principles which would result in the application of the laws of another state, provided, however, that (i) the
      interpretation of the definition of Material Adverse Effect (and whether a Material Adverse Effect has occurred), (ii) the determination of the accuracy of any Acquisition Agreement Representations and whether as a result of any inaccuracy thereof
      you (or any of your affiliates) have the right to terminate your (or its) obligations (or to refuse to consummate the Acquisition) under the Acquisition Agreement and (iii) the determination of whether the Acquisition has been consummated in
      accordance with the terms of the Acquisition Agreement, in each case shall be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to any choice of law or conflict of law provision or rule (whether
      of the State of Delaware or any other jurisdiction) that would cause the application of the law of any jurisdiction other than the State of Delaware.

    

    

    Each party hereto irrevocably waives all right to trial by jury in any action, proceeding or counterclaim (whether based on
      contract, tort or otherwise) arising out of or relating to this Commitment Letter, the Fee Letter, the Operative Documents, the transactions contemplated hereby or thereby or the actions of the parties hereto or any of their affiliates in the
      negotiation, performance or enforcement of this Commitment Letter, the Fee Letter or the Operative Documents.

     

    Each of the parties hereto irrevocably and unconditionally submits to the exclusive jurisdiction of any state or federal court sitting in The City of
      New York, Borough of Manhattan, over any suit, action or proceeding arising out of or relating to this Commitment Letter, the Fee Letter, the Operative Documents, the transactions contemplated hereby or thereby or the actions of the parties hereto or
      thereto or any of their affiliates in the negotiation, performance or enforcement of this Commitment Letter, the Fee Letter or the Operative Documents, and agrees that all claims in respect of any such action or proceeding shall be brought, heard and
      determined only in such New York State court or, to the extent permitted by law, in such federal court.  Service of any process, summons, notice or document by registered mail addressed to any such party shall be effective service of process against
      such person for any suit, action or proceeding brought in any such court.  Each of the parties hereto irrevocably and unconditionally waives any objection to the laying of venue of any such suit, action or proceeding brought in any such court and any
      claim that any such suit, action or proceeding has been brought in an inconvenient forum.  A final judgment in any such suit, action or proceeding brought in any such court may be enforced in any other courts to whose jurisdiction such party is or
      may be subject by suit upon judgment.

     

    
      10

      
        

    

    Section 13.           Payments.

     

    All payments under this Commitment Letter and the Fee Letter will, except as otherwise provided herein, be made in U.S. Dollars in New York, New York;
      without any set-off or reduction for any and all present future applicable taxes, levies, imposts, deductions, charges or withholdings imposed by any national, state or local taxing authority.

     

    To the fullest extent permitted by law, the Company will make all payments under this Commitment Letter and the Fee Letter regardless of any defense
      or counterclaim, including, without limitation, any defense or counterclaim based on any law, rule or policy which is now or hereafter promulgated by any governmental authority or regulatory body and which may adversely affect the Company’s
      obligation to make, or the right of the Commitment Parties to receive, such payments.

     

    Section 14.           Miscellaneous.

     

    This Commitment Letter and the Fee Letter contain the entire agreement between the parties relating to the subject matter hereof and supersede all
      oral statements and prior writings with respect thereto.  Section headings herein are for convenience only and are not a part of this Commitment Letter.  This Commitment Letter and the Fee Letter are solely for the benefit of the parties hereto and
      thereto (and Indemnified Persons, to the extent set forth in Section 6), and no other person shall acquire or have any rights under or by virtue of this Commitment Letter or the Fee Letter.  This Commitment Letter is not intended to create a
      fiduciary relationship among the parties hereto, and the Company waives, to the fullest extent permitted by law, any claims it may have against any of the Commitment Parties or any of their affiliates for breach of fiduciary duty or alleged breach of
      fiduciary duty in connection with the transactions contemplated by this Commitment Letter and agrees that none of the Commitment Parties or any of their affiliates shall have any liability (whether direct or indirect) to the Company in respect of
      such a fiduciary duty claim or to any person asserting such a fiduciary duty claim on behalf of or in right of the Company.  Any and all services to be provided by any of the Commitment Parties hereunder may be performed, and any and all rights of
      any of the Commitment Parties hereunder may be exercised, by or through any of such Commitment Party’s affiliates and branches, and, in connection with the provision of such services, each Commitment Party may exchange with such affiliates and
      branches information concerning the Company and the other companies that may be the subject of the transactions contemplated by this Commitment Letter and, to the extent so employed, such affiliates and branches shall be entitled to the benefits
      afforded to the Commitment Parties hereunder, subject to the confidentiality provisions herein.

     

    The indemnification, compensation, reimbursement, sharing of information, absence of fiduciary relationships, jurisdiction, governing law, venue,
      waiver of jury trial, syndication, market flex and confidentiality provisions contained herein and in the Fee Letter shall remain in full force and effect regardless of whether the Operative Documents shall be executed and delivered and
      notwithstanding the termination or expiration of this Commitment Letter or the Commitment Parties’ commitments hereunder; provided that your obligations under
      this Commitment Letter (other than your obligations with respect to (a) assistance to be provided in connection with the syndication thereof (including supplementing and/or correcting Information and Projections) prior to the Syndication Date and (b)
      confidentiality) shall automatically terminate and be superseded by the provisions of the Operative Documents upon the initial funding thereunder, in each case solely to the extent covered thereby with retroactive application to the date hereof.

     

    

    
      11

      
        

    

    We hereby notify you that pursuant to the requirements of the USA Patriot Act, Title III of Pub. L. 107-56 (signed into law October 26, 2001) (the “Patriot Act”) and the requirements of beneficial ownership certification required by 31 C.F.R. § 1010.230 (the “Beneficial Ownership Regulation”), we and the other Lenders may be required to obtain, verify and record information that identifies the borrower and each guarantor
      under the Operative Documents, which information includes the name, address and tax identification number and other customary information regarding any such borrower or guarantor that will allow us and the other Lenders to identify any such borrower
      or guarantor in accordance with the Patriot Act or Beneficial Ownership Regulation.  We and the other Lenders may also request corporate formation documents, or other forms of identification, to verify the information provided.  This notice is given
      in accordance with the requirements of the Patriot Act and Beneficial Ownership Regulation and is effective as to each Lender.  The Company hereby acknowledges and agrees that the Commitment Parties shall be permitted to share any or all such
      information with the Lenders.

     

    If any term, provision, covenant or restriction contained in this Commitment Letter is held by a court of competent jurisdiction to be invalid, void
      or unenforceable or against public policy, the remainder of the terms, provisions, covenants and restrictions contained herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated.  The Company and the
      Commitment Parties shall endeavor in good faith negotiations to replace the invalid, void or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, void or unenforceable
      provisions.

     

    This Commitment Letter may be executed in counterparts, each of which will be deemed an original, but all of which taken together will constitute one
      and the same instrument.  Delivery of an executed counterpart of a signature page of this Commitment Letter by facsimile or electronic (pdf) transmission shall be as effective as delivery of a manually executed counterpart hereof.

     

    Each of the parties hereto agrees that this Commitment Letter and the Fee Letter are binding and enforceable agreements with respect to the subject
      matter contained herein and therein, including an agreement to negotiate in good faith the Operative Documents by the parties hereto in a manner consistent with this Commitment Letter, it being acknowledged and agreed that the commitments provided
      hereunder by the Commitment Parties are subject only to the Funding Conditions.

    

    

    If the foregoing correctly sets forth our agreement with you, please indicate your acceptance of the terms of this Commitment Letter and of the Fee
      Letter by returning executed counterparts to this Commitment Letter and the Fee Letter to Justin Tichauer (on behalf of the Commitment Parties), Citigroup Global Markets Inc., 388 Greenwich Street, New York, New York 10013 (or by electronic (pdf)
      transmission to justin.s.tichauer@citi.com) at or before 11:59 p.m. (New York City time) on February 6, 2020.  If you do not return such executed counterparts prior to the date and time provided above, the commitment and other obligations of the
      Commitment Parties set forth in this Commitment Letter will automatically terminate.  Please arrange for the executed originals to follow by next-day courier.

    

    

    [Signature Pages Follow]

     

    
      12

      
        

    

    	 	
            Very truly yours,

          
	 	 
	
            .

          	
            CITIGROUP GLOBAL MARKETS INC

          
	 	 
	 	
            By:

          	
            /s/ Justin Tichauer

          
	 	 	
            Name: Justin Tichauer

          
	 	 	
            Title: Managing Director

          

    

    

    [Signature Page to Commitment Letter]

    

    

    
      
        

    

    ACCEPTED and agreed to as of the date

    first written above:

     

    	 	
            SCIENCE APPLICATIONS

          
	 	
            INTERNATIONAL CORPORATION

          
	 	 
	 	
            By:

          	/s/ Charles A. Mathis
	 	 	
            Name: Charles A. Mathis

          
	 	 	
            Title: Chief Financial Officer

          

    

    

    [Signature Page to Commitment Letter]

    

    

    
      
        

    

    
    Exhibit A

    to

    Commitment Letter

     

    Transactions Description

     

    All capitalized terms used herein but not defined herein shall have the meanings provided in the letter agreement to which this Exhibit A is attached
      or in the other Exhibits to such letter agreement, as applicable.  The following transactions in items 1-4 are referred to herein collectively as the “Transactions”.

     

    
      
        	

              	1.	
                The Company will obtain a new senior secured credit facility, comprised of a senior secured term
                    loan “B” credit facility in an aggregate principal amount of up to $600.0 million with the terms set forth in Exhibit B to the Commitment Letter (the “Term Loan B Incremental Facility”) as an incremental facility under the Company’s Third Amended and
                  Restated Credit Agreement, dated as of October 31, 2018, (as amended from time to time prior to the date hereof, the “Existing Credit
                    Agreement”), among the Company, the Lenders from time to time party thereto and Citibank, N.A., as Administrative Agent and Collateral Agent.

              

      

    

     

    
      
        	

              	2.	
                The Company will issue up to $400.0 million of debt securities (the “Notes”)
                  and/or borrow up to the unissued amount of such issuance in the form of loans under a $400.0 million senior unsecured bridge facility with the terms set forth in Exhibit C (the “Bridge Facility” and together with the Term Loan B Incremental Facility, the “Facilities”),
                  in each case on the Closing Date.

              

      

    

     

    
      
        	

              	3.	
                The Company or one of its wholly-owned subsidiaries will complete the acquisition (the “Acquisition”) of the Acquired Business pursuant to the Asset Purchase Agreement, dated as of the date hereof by and among Unisys Corporation and Science Applications International Corporation (together with
                  all schedules, exhibits and annexes thereto, the “Acquisition Agreement”).

              

      

    

     

    
      
        	

              	4.	
                The Company will pay all fees, costs and expenses incurred in connection with the foregoing transactions (including debt prepayment premiums, if any).

              

      

    

     

    
      A-1

      
        

    

    
    Exhibit B

    to

    Commitment Letter

     

    $600.0 million Senior Secured Term Loan B Facility

    Summary of Principal Terms and Conditions

     

      February 2020

     

    All capitalized terms used herein but not defined herein shall have the meanings provided in the letter agreement to which this Exhibit B is attached,
      in the other Exhibits to such letter agreement or in the Existing Credit Agreement, as applicable.

    

    

    	
            Borrower:

          	 	
            Science Applications International Corporation, a Delaware corporation (the “Borrower”).

          
	 	 	 
	
            Administrative Agent and Collateral Agent:

          	 	
            Citi, will continue to act as sole administrative agent and collateral agent (in such capacities, the “Term Loan B Agent”) for a syndicate of banks, financial institutions,
              investors and other lenders (the “Term Loan B Lenders”), and will perform the duties customarily associated with such roles.

          
	 	 	 
	
            Arranger:

          	 	
            Citi, together with any other joint bookrunner or joint lead arranger appointed pursuant to the Commitment Letter, will act as joint bookrunners and lead
              arrangers for the Term Loan B Incremental Facility and will perform the duties customarily associated with such roles.

          
	 	 	 
	
            Facility:

          	 	
            A senior secured term loan “B” facility in an aggregate principal amount of $600.0 million which will be incurred as a Term Loan B Incremental Loan under the
              Existing Credit Agreement.

          
	 	 	 
	
            Purpose:

          	 	
            The proceeds of the Term Loan B Incremental Facility will be used on the Closing Date to consummate the Acquisition, including the payment of fees, costs and
              expenses in connection therewith.

          
	 	 	 
	
            Maturity and Amortization:

          	 	
            The Term Loan B Incremental Facility will mature on the date that is seven years following the Closing Date (the “Term Loan Maturity Date”) and will amortize in equal quarterly installments in an aggregate annual amount equal to 1.00% of the original principal amount of the Term Loan B
              Incremental Facility, beginning with the first full fiscal quarter ending after the Closing Date, with the balance payable on the maturity date of the Term Loan B Incremental Facility.

          
	 	 	 
	
            Guarantees:

          	 	
            All obligations of the Borrower under the Term Loan B Incremental Facility will be unconditionally guaranteed on a joint and several basis and on a senior
              secured first lien basis (the “Guarantees”) by each direct or indirect domestic subsidiary of the Borrower (whether owned on the
              Closing Date or formed or acquired thereafter) (the “Guarantors”), in each case subject to customary exceptions and limitations
              consistent with the Existing Credit Agreement.

          

    

    

    
      B-1

      
        

    

    	
            Security:

          	 	
            All obligations of the Borrower under the Term Loan B Incremental Facility and the Guarantees and will be secured on a first-priority basis by substantially all
              the assets of the Borrower and each of the Guarantors (collectively, the “Collateral”), subject to customary exceptions and
              limitations consistent with the Existing Credit Agreement.

          
	 	 	 
	
            Mandatory Prepayments:

          	 	
            On the same basis provided for under the Existing Credit Agreement. The mandatory prepayments will be allocated pro rata among the outstanding loans under the
              Term Facilities and Tranche B Facilities under (and as defined in) the Existing Credit Agreement and the Term Loan B Incremental Facility.

          
	 	 	 
	
            Voluntary Prepayments/ Reductions in Commitments:

          	 	
            On the same basis provided for under the Existing Credit Agreement.

          
	 	 	 
	
             

            Call Protection:

          	 	
            The occurrence of any Repricing Event prior to the date that is six months after the Closing Date will require payment of a fee in an amount equal to 1.00% of
              the aggregate principal amount of the loans under the Term Loan B Incremental Facility subject to such Repricing Event.

          
	 	 	 
	
            Interest Rates:

          	 	
            At the Borrower’s option, loans under the Term Loan B Incremental Facility
              may be maintained from time to time as (x) “Base Rate Loans”, which will bear interest at the Base Rate (or, if greater at any time,
              the Base Rate Floor, if applicable) in effect from time to time plus the Applicable Margin or (y) “LIBOR Loans”, which will bear interest at the London interbank offered rate for U.S. dollars (adjusted for statutory reserve requirements) as determined by the Term Loan B Agent for the
              respective interest period (or, if greater at any time, the LIBOR Floor, if applicable) plus the Applicable Margin.

          
	 	 	 
	 	 	
            “Applicable Margin” will mean a percentage per annum
              equal to:

             

            Loans under the Term Loan B Incremental Facility (x) maintained as Base Rate Loans, 1.25%, and (y) maintained as LIBOR Loans, 2.25%.

          
	 	 	 
	 	 	
            “Base Rate” will mean the highest of (x) the rate
              that the Term Loan B Agent announces from time to time as its prime lending rate, as in effect from time to time, (y) 1/2 of 1% in excess of the federal funds effective rate, and (z) the London interbank offered rate for U.S. dollars for an
              interest period of one month (adjusted for statutory reserve requirements) (which rate shall for this purpose not be less than 0%) plus 1.00%.

          

    

    

    
      B-2

      
        

    

    	 	 	
            “Base Rate Floor” will mean 1.00% per annum.

          
	 	 	 
	 	 	
            “LIBOR Floor” will mean 0.00% per annum.

          
	 	 	 
	 	 	
            Interest periods of 1, 2, 3 and 6 months or, to the extent agreed to by all applicable Term Loan B Lenders, 12 months, will be available in the case of LIBOR
              Loans; provided that the initial interest period for any LIBOR Loans made on the Closing Date may be at the then applicable one-month LIBOR for a
              period of less than one month and at the then applicable three-month LIBOR for a period of less than three months.

          
	 	 	 
	 	 	
            Interest in respect of Base Rate Loans will be payable quarterly in arrears on the last business day of each calendar quarter.  Interest in respect of LIBOR
              Loans will be payable in arrears at the end of the applicable interest period and every three months in the case of interest periods in excess of three months.  Interest will also be payable at the time of repayment of any loans and at
              maturity.  All interest on Base Rate Loans, LIBOR Loans and, if applicable, any fees will be based on a 360-day year and actual days elapsed (or, in the case of Base Rate Loans determined by reference to the prime lending rate, a 365/366-day
              year and actual days elapsed).

          
	 	 	 
	
            Default Interest:

          	 	
            As per the Existing Credit Agreement.

          
	 	 	 
	
            Representations and Warranties:

          	 	
            As per the Existing Credit Agreement.

          
	 	 	 
	
            Affirmative Covenants:

          	 	
            As per the Existing Credit Agreement.

          
	 	 	 
	
            Negative Covenants:

          	 	
            As per the Existing Credit Agreement.

          
	 	 	 
	
            Financial Maintenance Covenant:

          	 	
            None.

          
	 	 	 
	
            Events of Default:

          	 	
            As per the Existing Credit Agreement.

          
	 	 	 
	
            Voting:

          	 	
            As per the Existing Credit Agreement.

          
	 	 	 
	
            Cost and Yield Protection:

          	 	
            As per the Existing Credit Agreement.

          
	 	 	 
	
            Assignments and Participation:

          	 	
            As per the Existing Credit Agreement.

          
	 	 	 
	
            Expenses and Indemnification:

          	 	
            As per the Existing Credit Agreement.

          
	 	 	 
	
            Governing Law; Forum:

          	 	
            New York.

          
	 	 	 
	
            Counsel to Term Loan B Agent and Arrangers:

          	 	
            Shearman & Sterling LLP.

          

    

    

    
      B-3

      
        

    

    
    Exhibit C

    to

    Commitment Letter

     

    $400.0 million Senior Unsecured Bridge Facility

    Summary of Principal Terms and Conditions

    

    

    	
            Initial Bridge Loans:

          	 	
            The Bridge Lenders (as defined below) will make loans (the “Initial
                Bridge Loans”) to the Borrower on the Closing Date in an aggregate principal amount equal to (or, in the discretion of the Borrower, less than) (i) $400.0 million (or such lesser amount as necessary to be in compliance with the limit
              on debt incurrence applicable to the Borrower in Section 5.03(k)(vii) of the Existing Credit Agreement) minus (ii) the aggregate principal amount of the Notes (or “demand” securities issued in lieu thereof) issued on or prior to the Closing
              Date.

          
	 	 	 
	
            Borrower:

          	 	
            Same as the Term Loan B Incremental Facility.

          
	 	 	 
	
            Guarantees:

          	 	
            Same as the Term Loan B Incremental Facility.

          
	 	 	 
	
            Administrative Agent:

          	 	
            Citi will act as sole administrative agent (in such capacity the “Bridge Agent” and together with the Term Loan B Agent, the “Agents”) for a syndicate of banks, financial institutions, investors and other lenders, excluding any Disqualified Institutions (Citi, together with such lenders on the Closing Date,
              the “Bridge Lenders”), and will perform the duties customarily associated with such roles.

          
	 	 	 
	
            Arranger:

          	 	
            Citi, together with any other joint bookrunner or joint lead arranger appointed pursuant to the Commitment Letter, will act as joint bookrunners and lead
              arrangers for the Bridge Facility and will perform the duties customarily associated with such roles.

          
	 	 	 
	
            Purpose:

          	 	
            The proceeds of the Initial Bridge Loans will be used by the Borrower on the Closing Date to consummate the Acquisition, including the payment of fees, costs and
              expenses in connection therewith.

          
	 	 	 
	
            Funding/Availability:

          	 	
            The Initial Bridge Loans will be made in a single drawing on the Closing Date in an aggregate principal amount determined as set forth under “Initial Bridge
              Loans” above.

          
	 	 	 
	
            Maturity/Exchange:

          	 	
            All the Initial Bridge Loans will mature on the date that is one year following the Closing Date (the “Initial Bridge Loan Maturity Date”).  If any Initial Bridge Loan has not been previously repaid in full on or prior to the Initial Bridge Loan Maturity Date and so long as no payment or bankruptcy default or event of default
              has occurred and is continuing, such Initial Bridge Loan shall automatically be extended into a senior unsecured term loan (each an “Extended Bridge Loan”) due on the date
              that is eight years after the Closing Date (the “Final Bridge Loan Maturity Date”) having the terms set forth in the term sheet attached hereto as Annex I.  The Bridge
              Lender in respect of such Extended Bridge Loan will have the option at any time or from time to time to receive Exchange Notes (the “Exchange Notes”) in exchange for such
              Extended Bridge Loan having the terms set forth in the term sheet attached hereto as Annex II; provided, however,
              that the Borrower may defer the first issuance of Exchange Notes until such time as the Borrower shall have received requests to issue an aggregate of at least $100.0 million in aggregate principal amount of Exchange Notes and shall not be
              required to issue Exchange Notes more than a number of times to be agreed in any calendar month.

          

    

    

    
      B-1

      
        

    

    	 	 	
            The Initial Bridge Loans, the Extended Bridge Loans and the Exchange Notes shall be pari passu for all purposes.

          
	 	 	 
	
            Interest:

          	 	
            Prior to the Initial Bridge Loan Maturity Date, the Initial Bridge Loans will accrue interest at a rate per annum equal to LIBOR plus a spread of 3.00% (such
              spread, the “LIBOR Bridge Spread”) or Base Rate plus a spread of 2.00% (such spread, the “Base Rate Bridge Spread” and together with the LIBOR Bridge Spread, the “Bridge
                Spread”).  If the Initial Bridge Loans are not repaid in whole within three months following the Closing Date, the Bridge Spread will increase by 50 basis points at the end of such three-month period and will increase by an
              additional 50 basis points at the end of each three-month period thereafter until the Initial Bridge Loan Maturity Date; provided that in no event will the Initial Bridge
              Loans accrue interest at a rate per annum in excess of the Total Cap (as defined in the Fee Letter) (excluding interest at the default rate as described below).

          
	 	 	 
	 	 	
            Calculation of interest shall be on the basis of actual days elapsed in a year of 360 days (or 365 or 366 days, as the case may be, in the case of Base Rate
              Loans).

          
	 	 	 
	 	 	
            At the Borrower’s option, the Initial Bridge Loans may be maintained from time to time as (x) “Base Rate Loans”, which shall bear interest at the Base Rate (or, if greater at any time, the Base Rate Floor, if applicable) in effect from time to time plus the Base Rate Bridge Spread or (y) “LIBOR Loans”, which shall bear interest at the
              London interbank offered rate for U.S. dollars (adjusted for statutory reserve requirements) as determined by the Bridge Agent for the respective interest period (or, if greater at any time, the LIBOR Floor, if applicable) plus the LIBOR Bridge Spread.

            “Base Rate” shall mean the highest of (x) the rate
              that the Bridge Agent announces from time to time as its prime lending rate, as in effect from time to time, (y) 1/2 of 1% in excess of the federal funds effective rate, and (z) the London interbank offered rate for U.S. dollars for an
              interest period of one month (adjusted for statutory reserve requirements) plus 1.00%.

             

            

            “Base Rate Floor” shall mean 1.00% per annum.

             

            

            “LIBOR Floor” shall mean 0.00 % per annum.

          
	 	 	 
	 	 	
            Interest will be payable in arrears at the end of each fiscal quarter of the Borrower following the Closing Date and on the Initial Bridge Loan Maturity Date.

          
	 	 	 
	
            Default Rate:

          	 	
            With respect to overdue principal and interest, and other overdue amounts, the applicable interest rate plus 2.00% per annum.

             

            

            Upon the occurrence and during the continuance of any Event of Default, each LIBOR Loan will convert to a Base Rate Loan at the end of the interest period then
              in effect for such LIBOR Loan.

          

     

    

    
      B-2

      
        

    

    	
            Mandatory Prepayments:

          	 	
            The Borrower will be required to prepay Initial Bridge Loans on a pro rata basis, at par plus accrued and unpaid interest (a) with 100% of the net cash proceeds of (i) any direct or indirect public offering or private placement of debt securities
              of the Company or any of the Company’s subsidiaries or any equity securities of the Company; provided that in the event any Bridge Lender or affiliate of a Bridge Lender
              purchases debt securities from the Borrower pursuant to a Permanent Debt Notice (as defined in the Fee Letter) at an issue price above the level at which such Bridge Lender or affiliate has determined such debt securities can be resold by
              such Bridge Lender or affiliate to a bona fide third party at the time of such purchase (and notifies the Borrower thereof), the net cash proceeds received by the Borrower in respect of such debt securities may, at the option of such Bridge
              Lender or affiliate, be applied first to repay the Initial Bridge Loans of such Bridge Lender or affiliate (provided that if there is more than one such Bridge Lender or
              affiliate then such net cash proceeds will be applied pro rata to repay Initial Bridge Loans of all such Bridge Lenders or affiliates in proportion to such Bridge Lenders’ or affiliates’ principal amount of debt securities purchased from the
              Borrower) prior to being applied to prepay the Initial Bridge Loans held by other Bridge Lenders, (ii) the incurrence of any indebtedness by the Borrower or any subsidiary of the Borrower (other than borrowings under the Existing Credit
              Agreement, as applicable and certain permitted indebtedness), (iii) all non-ordinary course asset sales or other dispositions of property by the Company and its subsidiaries in excess of $10.0 million (individually or from any series of
              related transactions) (including, without limitation, insurance and condemnation proceeds) (subject to exceptions and reinvestment provisions as set forth in the Existing Credit Agreement) and (iv) any Receivables Facility (as defined in the
              Existing Credit Agreement), in the case of (ii) and (iii),  subject to the prior repayment of all amounts required to be repaid under the Existing Credit Agreement.

          
	 	 	 
	
            Offer to Prepay upon a Change of Control:

          	 	
            The Borrower will be required to offer to prepay Initial Bridge Loans at 100% of par plus accrued and unpaid interest upon the occurrence of a change of control.

          
	 	 	 
	
            Optional Prepayment:

          	 	
            The Initial Bridge Loans may be prepaid, in whole or in part, at the option of the Borrower, at any time upon three days’ prior notice, at par plus accrued and
              unpaid interest, subject to reimbursement of the Bridge Lenders’ actual redeployment costs in the case of a prepayment of LIBOR borrowings other than on the last day of the relevant interest period.

          
	 	 	 
	
            Documentation:

          	 	
            Consistent with the Existing Credit Agreement, with modifications customary for transactions of this type, consistent with this Commitment Letter and the Fee
              Letter.

          
	 	 	 
	
            Representations and Warranties:

          	 	
            Consistent with the Existing Credit Agreement, with modifications customary for transactions of this type, subject to the Limited Conditionality Provisions and
              consistent with this Commitment Letter and the Fee Letter.

          
	 	 	 
	
            Conditions Precedent:

          	 	
            The funding of the Initial Bridge Loans shall be subject to only the Funding Conditions.

          
	 	 	 
	
            Refinancing:

          	 	
            The Borrower will use commercially reasonable efforts to refinance the Initial Bridge Loans as promptly as practicable after the Closing Date with the Notes.

          
	 	 	 
	
            Covenants:

          	 	
            Consistent with the Existing Credit Agreement, with modifications customary for high yield debt securities; provided that, prior to the Initial Bridge Loan Maturity Date, the debt incurrence, liens and restricted payments covenants will be more restrictive, as determined by the Arrangers in their reasonable
              discretion.

          

    

    

    
      B-3

      
        

    

    	
            Events of Default:

          	 	
            As per the Existing Credit Agreement.

          
	 	 	 
	 	 	
            Following the Initial Bridge Loan Maturity Date, the events of default relevant to the Initial Bridge Loans will be automatically modified to be consistent with
              the Exchange Notes.

          
	 	 	 
	
            Cost and Yield Protection:

          	 	
            As per the Existing Credit Agreement.

          
	 	 	 
	
            Assignment and Participation:

          	 	
            As per the Existing Credit Agreement.

          
	 	 	 
	
            Voting:

          	 	
            As per the Existing Credit Agreement.

          
	 	 	 
	
            Expenses and Indemnification:

          	 	
            As per the Existing Credit Agreement.

          
	 	 	 
	
            Governing Law and Forum:

          	 	
            New York.

          
	 	 	 
	
            Counsel to the Bridge Agent and the Arrangers:

          	 	
            Shearman & Sterling LLP.

          

    

    

    
      B-4

      
        

    

    
     Annex I

    Summary of Principal Terms and Conditions

    of Extended Bridge Loans

     

    Capitalized terms used but not defined herein have the meanings given in the Summary of Principal Terms and Conditions of the $400.0 million Bridge Facility to which this
      Annex I is attached.

    

    

    	
            Maturity:

          	 	
            The Extended Bridge Loans will mature on the eighth anniversary of the Closing Date.

          
	 	 	 
	
            Interest Rate:

          	 	
            The Extended Bridge Loans will accrue interest at a rate per annum equal to the Total Cap (as defined in the Fee Letter) (excluding interest at the default rate
              as described below).

          
	 	 	 
	 	 	
            Interest will be payable in arrears at the end of each fiscal quarter of the Borrower following the Initial Bridge Loan Maturity Date and on the maturity date of
              the Extended Bridge Loans.

          
	 	 	 
	
            Default Rate:

          	 	
            With respect to overdue principal and interest, and other overdue amounts, the applicable interest rate plus 2.00% per annum.

            Upon the occurrence and during the continuance of any Event of Default each LIBOR Loan will convert to a Base Rate Loan at the end of the interest period then in
              effect for such LIBOR Loan.

          
	 	 	 
	
            Guarantees:

          	 	
            Same as the Initial Bridge Loans.

          
	 	 	 
	
            Offer to Prepay upon a Change of Control:

          	 	
            The Borrower will be required to offer to prepay Extended Bridge Loans at par plus accrued and unpaid interest upon the occurrence of a change of control.

          
	 	 	 
	
            Optional Prepayment:

          	 	
            The Extended Bridge Loans may be prepaid, in whole or in part, at the option of the Borrower, at any time upon three days’ prior notice, at par plus accrued and
              unpaid interest.

          
	 	 	 
	
            Covenants, Events of Default and Offers to Repurchase:

          	 	
            The covenants, events of default and offers to repurchase upon asset sales that would be applicable to the Exchange Notes, if issued, will also be applicable to
              the Extended Bridge Loans in lieu of the corresponding provisions applicable to the Initial Bridge Loans.

          
	 	 	 
	
            Conditions to Conversion to Extended Bridge Loans:

          	 	
            Payment of the Exchange Fee (as defined in the Fee Letter).

          
	 	 	 
	
            Governing Law and Forum:

          	 	
            New York.

          

    

    

    
      B-1

      
        

    

    
    Annex II

    

    

    Summary of Principal Terms and Conditions

    of Exchange Notes

     

    Capitalized terms used but not defined herein have the meanings given in the Summary of Principal Terms and Conditions of the $400.0 million Bridge Facility to which this
      Annex II is attached.

    

    

    	
            Issuer:

          	 	
            The Borrower will issue Exchange Notes under an indenture (the “Indenture”).  The Borrower
              in its capacity as issuer of the Exchange Notes is referred to as the “Issuer”.

          
	 	 	 
	
            Guarantees:

          	 	
            Same as the Initial Bridge Loans.

          
	 	 	 
	
            Principal Amount:

          	 	
            The Exchange Notes will be available only in exchange for the Extended Bridge Loans.  The principal amount of any Exchange Note will equal 100% of the aggregate
              principal amount of the Extended Bridge Loan for which it is exchanged.

          
	 	 	 
	
            Maturity:

          	 	
            The Exchange Notes will mature on the eighth anniversary of the Closing Date.

          
	 	 	 
	
            Interest Rate:

          	 	
            The Exchange Notes will accrue interest at a rate per annum equal to the Total Cap (as defined in the Fee Letter) (excluding interest at the default rate as
              described below).

          
	 	 	 
	 	 	
            Interest will be payable semi-annually in arrears.

          
	 	 	 
	
            Default Rate:

          	 	
            With respect to overdue principal and interest, and other overdue amounts, the applicable interest rate plus 2.00% per annum.

          
	 	 	 
	
            Offer to Repurchase upon a Change of Control:

          	 	
            The Borrower will be required to offer to purchase Exchange Notes at 101% of par plus accrued and unpaid interest upon the occurrence of a change of control.

          
	 	 	 
	
            Offer to Repurchase from Asset Sale Proceeds:

          	 	
            The Borrower will be required to offer to purchase Exchange Notes (and, if outstanding, prepay Extended Bridge Loans) on a pro rata basis at 100% of par plus
              accrued and unpaid interest with a portion of the net cash proceeds from any non-ordinary course asset sales or other dispositions of property by the Borrower and its subsidiaries in excess of amounts paid to the lenders under the Existing
              Credit Agreement, with such proceeds being applied to the Exchange Notes, the Extended Bridge Loans and the Debt Securities in a manner to be agreed upon, subject to thresholds, reinvestment rights and other limited exceptions to be agreed
              upon.

          
	 	 	 
	
            Optional Redemption:

          	 	
            Except as set forth in the next two succeeding paragraphs, the Exchange Notes will be non-callable until the third anniversary of the Closing Date.  Thereafter,
              each Exchange Note will be callable at par plus accrued and unpaid interest plus a premium equal to 50% of the coupon on such Exchange Note, which premium shall decline ratably on each subsequent anniversary of the Closing Date thereafter to
              zero on the date that is two years prior to the maturity date of the Exchange Notes.

          

    

    

    
      D-1

      
        

    

    	 	 	
            Prior to the third anniversary of the Closing Date, the Borrower may redeem such Exchange Notes subject to a customary T + 50 basis points “make-whole”
              redemption.

            Prior to the third anniversary of the Closing Date, the Borrower may redeem up to 40% of such Exchange Notes with an amount equal to proceeds from any equity
              offering at a price equal to par plus the coupon plus accrued interest on such Exchange Notes.

          
	 	 	 
	
            Registration Rights:

          	 	
            None.  144A for life.

          
	 	 	 
	
            Right to Transfer Exchange Notes:

          	 	
            The holders of the Exchange Notes shall have the absolute and unconditional right to transfer such Exchange Notes in compliance with applicable law to any third
              parties.

          
	 	 	 
	
            Covenants:

          	 	
            Substantially the same as those applicable to the Initial Bridge Loans.  For the avoidance of doubt, there shall be no financial maintenance covenants.

          
	 	 	 
	
            Events of Default:

          	 	
            Substantially the same as those applicable to the Initial Bridge Loans.

          
	 	 	 
	
            Governing Law and Forum:

          	 	
            New York.

          

     

    

    
      D-2

      
        

    

    
    Exhibit D

    to

    Commitment Letter

     

    Summary of Additional Conditions Precedent

     

    All capitalized terms used herein but not defined herein shall have the meanings provided in the letter agreement to which this Exhibit D is attached
      or in the other Exhibits to such letter agreement, as applicable.  The initial borrowing under the Facilities shall be subject to the following additional conditions precedent:

     

    1.          The Acquisition shall be consummated
        substantially contemporaneously with the initial funding under the Term Loan B Incremental Facility in accordance with the terms described in the Acquisition Agreement (without any amendment, modification, supplement or waiver thereof or any
        consent or election thereunder that is material and adverse to the Lenders or the Arrangers without the prior written consent of the Arrangers, which consent shall not be unreasonably withheld, conditioned or delayed). It being understood and
        agreed that (x) any amendment that decreases the purchase price by less than 10.0% shall not be deemed to be materially adverse to the Lenders or the Arrangers so long as such decrease is allocated to reduce the Term Loan B Incremental Facility
        dollar for dollar; (y) any amendment that increases the purchase price shall not be deemed materially adverse to the Lenders or the Arrangers if such increase is not funded with debt; and (z) any amendment, modification, waiver or consent that
        results in a change to the definition of Material Adverse Effect shall be deemed to be materially adverse to the Lenders and the Arrangers.

     

    2.           The Acquisition
        Agreement Representations shall be true and correct to the extent required by the Limited Conditionality Provisions and the Specified Representations shall be true and correct in all material respects (or in all respects, if qualified by
        materiality).

     

    3.           Subject to the
        Limited Conditionality Provisions, the Arrangers shall have received reasonably satisfactory legal opinions, perfection certificates, corporate/organizational documents and officers’ and public officials’ certifications; a customary notice of
        borrowing; lien search results (to the extent requested at least fifteen business days prior to the Closing Date); customary evidence of authorization to enter into the Operative Documents; and good standing certificates in jurisdictions of
        formation/organization, in each case of the Company and the Guarantors.  The Agents shall have received a customary solvency certificate from the chief financial officer of the Borrower in the form of Exhibit H to the Existing Credit Agreement and
        attached hereto as Exhibit E.

     

    4.           Subject in all
        respects to the Limited Conditionality Provisions, the Term Loan B Agent shall have a perfected, first priority lien on and security interest in all Collateral (free and clear of all liens, other than customary exceptions to be agreed upon,
        consistent with the Existing Credit Agreement).

     

    5.           All fees required to be paid on the Closing Date pursuant to the Commitment Letter and the Fee Letter and out-of-pocket expenses required to be paid on the Closing Date pursuant to the Commitment
          Letter (to the extent invoiced at least three days prior to the Closing Date) shall, upon the initial borrowing under the Term Loan B Incremental Facility,
          have been paid.

     

    6.           Each of the Arrangers shall have received, at least three business days prior to the Closing Date, all documentation and other information required by regulatory authorities under applicable “know
          your customer”, anti-money laundering rules and regulations, including, without limitation, the PATRIOT Act, and the Company shall deliver a certification substantially similar in form and substance to the form of Certification Regarding
        Beneficial Owners of Legal Entity Customers published jointly, in May 2018, by the Loan Syndications and Trading Association and Securities Industry and Financial Markets Association, that such Arranger has requested at least ten business days prior to the Closing Date.

     

    
      D-1

      
        

    

    7.           The Arrangers shall have received
        (a) (i) audited consolidated balance sheets and related statements of income and cash flows of the Company and its consolidated subsidiaries for the fiscal years ended February 3, 2017, February 2, 2018 and February 1, 2019 (it being agreed by the
        Arrangers that such financials have been received) and each subsequent fiscal year ended at least 90 days prior to the Closing Date and (ii) unaudited consolidated balance sheets and related statements of income and cash flows of the Company and
        its consolidated subsidiaries for November 2, 2019 and each subsequent fiscal quarter (other than any fourth fiscal quarter) ended after November 2, 2019 and at least 45 days prior to the Closing Date, (b) (i) audited consolidated balance sheets
        and related statements of income and cash flows of the Acquired Business for the fiscal year ended  December 31, 2019 and each subsequent fiscal year ended at least 90 days prior to the Closing Date, and (ii) unaudited consolidated balance sheets
        and related statements of income and cash flows of the Acquired Business for September 30, 2019 (it being agreed by the Arrangers that the September 30, 2019 financials have been received) and each subsequent fiscal quarter ended after September
        30, 2019 and at least 45 days prior to the Closing Date and (c) a pro forma consolidated balance sheet and related pro forma consolidated statement of income of the Company as of, and for the twelve-month period ending on, the last day of the most
        recently completed four-fiscal quarter period for which financial statements of the Company pursuant to clause (a) above have been delivered, in each case prepared after giving effect to the Transactions as if the Transactions had occurred as of
        such date (in the case of such balance sheet) or at the beginning of such period (in the case of such income statement). 

     

    8.           With respect to the Bridge Facility,
        (I) investment banks reasonably acceptable to the Commitment Party (the “Investment Banks”) shall have been engaged to publicly sell or
        privately place the Notes pursuant to the engagement letter among the Investment Banks and the Company and (II) the Company shall have delivered to the Investment Banks a customary preliminary offering memorandum that is suitable for use in a
        customary high‐yield road show relating to the Notes that contains all financial statements (including all audited financial statements, all unaudited financial statements (which shall have been reviewed by the independent accountants for the
        Company or the Acquired Business, as applicable, as provided in Statement on Auditing Standards No. 100) and all appropriate pro forma financial statements prepared in accordance with U.S. GAAP and prepared in accordance with Regulation S‐X under
        the Securities Act of 1933, as amended) and all other data (including selected financial data) that is customarily included in a customary 144A for life offering of the Notes or that would be necessary for the Investment Banks to receive customary
        “comfort” (including “negative assurance” comfort) from independent accountants in connection with the offering of the Notes.  Upon delivery of such preliminary offering memorandum, the Company shall have caused its senior management personnel to
        have participated in a customary road show for the sale of the Notes for a period of not less than 15 consecutive business days (the “Marketing
          Period”); provided that to the extent such period has not been completed on or
          prior to March 14, 2020, such period may not begin until April 1, 2020.

     

    
      D-2

      
        

    

    Exhibit E

    to

    Commitment Letter

    

    

    SOLVENCY CERTIFICATE

    _________________, [2020]

    

    

              This Solvency Certificate is being executed and delivered pursuant to the amendment to Credit Agreement (as defined below) dated
        as of ________________, 2020 (the “Incremental Amendment”) by and among Citibank, N.A., as the Administrative Agent and Collateral Agent (in such capacities “Agent”), Science Applications International Corporation, a Delaware corporation (“Company”) and
        the other parties party thereto. Unless otherwise defined herein, capitalized terms used in this Solvency Certificate shall have the meanings set forth in the Third Amended and Restated Credit Agreement dated as of October 31, 2018 (as amended,
        supplemented or otherwise modified from time to time, the “Credit Agreement”), among Company, the lenders from time to time party thereto and Agent.

    

    

    I, Charles Mathis, the Chief Financial Officer of Company, in such capacity and not in an individual capacity, hereby certify as follows:

    

    

    
      
        	

              	1.	
                I am generally familiar with the businesses and assets of Company and its Subsidiaries, taken as a whole, and I am duly authorized to execute this Solvency Certificate on behalf
                  of Company; and

              

      

    

     

    
      
        	

              	2.	
                as of the date hereof and after giving effect to the Transactions (as such term is defined in the Incremental Amendment) and the incurrence of the indebtedness and obligations
                  being incurred in connection therewith, that:

              

      

    

     

    
      
        	

              	(i)	
                the sum of the “fair value” of the assets of Company and its Subsidiaries, taken as a whole, exceeds the sum of all debts (including subordinated debt or contingent liabilities)
                  of Company and its Subsidiaries, taken as a whole;

              

      

    

     

    
      
        	

              	(ii)	
                the “present fair saleable value” of the assets of Company and its Subsidiaries, taken as a whole, is greater than the amount that will be required to pay the probable liability
                  on existing debts (including subordinated debt or contingent liabilities) of Company and its Subsidiaries, taken as a whole, as such debts become absolute and matured;

              

      

    

     

    
      
        	

              	(iii)	
                the capital of Company and its Subsidiaries, taken as a whole, is not unreasonably small in relation to the business of Company and its Subsidiaries, taken as a whole,
                  contemplated as of the date hereof; and

              

      

    

     

    
      
        	

              	(iv)	
                Company and its Subsidiaries, taken as a whole, do not intend to incur, or believe that they will incur, debts and liabilities (including current obligations and contingent
                  liabilities) beyond their ability to pay such debt as they mature in the Ordinary Course of Business.

              

      

    

     

              For the purposes hereof, the amount of any contingent liability at any time shall be computed as the amount that, in light of all
        of the facts and circumstances existing at such time, represents the amount that can reasonably be expected to become an actual or matured liability.

    

    

    [Signature Page Follows]

    

    

  

  E-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00303-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00303-of-00352.parquet"}]]